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 Given the limited knowledge surrounding calf-rearing systems a series of 
studies were developed to address some of the aspects regarding colostrum and whole 
milk (non-saleable or hospital milk) physical process (Chapter 1), supplementation of 
trace minerals (Chapter 2), non-antimicrobial alternatives to prevent and control 
neonatal calf diarrhea (Chapter 3 and 4), antimicrobial metaphylactic interventions in 
high-risk group of animals (Chapter 5), and pulmonary lesions in dairy heifers at 
weaning (Chapter 6). 
Alternatives to heat-treatment of colostrum and non-saleable milk using 
ultraviolet light herein explored showed decreased levels of immunoglobulins in 
colostrum. Ultraviolet light and heat treatment decreased microorganism 
contamination. However, colostrum and non-saleable milk treatments were not 
associated with calf survivability, incidence of diseases (diarrhea and pneumonia), and 
average daily weight gain during the pre-weaning period. Injectable trace minerals 
supplementation improved leukocyte function and oxidative stress levels in dairy 
calves. However, these benefits did not translate to improved growth performance and 
health status for dairy calves in the first 60 days of life.  
Enteric-coated crofelemer extract, a natural-product with anti-secretory 
properties produced an increase in fecal dry matter in diarrheic neonatal calves in a 
  
challenge study. Furthermore, when the natural extract was administered 
prophylactically for the first two weeks of life, milk fed calves experienced fewer 
events of diarrhea and reduced use of fluid therapy when compared to non-treated 
calves. A metaphylactic intervention using a synthetic long acting macrolide decreased 
the combined incidence of respiratory disease and otitis in high-risk group-housed 
replacement heifers during the pre-weaning period. Finally, nulliparous heifers 
suffered consequences from lung consolidation detected at weaning through a 
decrease in reproductive performance and an increase in culling risk. 
 There are many important aspects on prevention and treatment of diseases 
affecting replacement dairy heifers. Strategically, different approaches can be used to 
improve replacement heifers’ health and performance. 
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ABSTRACT 
 The aim of this study was to evaluate the effects of different physical 
treatments of bovine colostrum and hospital milk (non-saleable) on milk bacteriology, 
immunoglobulin G (IgG) and lactoferrin concentrations, calf serum IgG 
concentrations and calf health, growth, and survivability. Pooled colostrum samples (n 
= 297) were heat treated (HTC; 63 °C for 60 minutes), exposed to ultraviolet light 
(UVC; 45 J/cm
2) or untreated (‘raw’ colostrum, RC). Hospital milk (n = 712) was 
subjected to high temperature short time pasteurization (HTST; 72 °C for 15 seconds) 
and ultraviolet light irradiation (UVH; 45 J/cm
2
). Neonatal Holstein heifer calves (n = 
875) were randomly enrolled into one of three colostrum treatment groups; 309 in the 
HTC, 285 in the UVC, and 281 in the RC. Once enrolled into a colostrum treatment, 
heifers were block randomized (by colostrum treatment) into two hospital milk 
treatments HTST (RC = 144, HTC = 152, and UVC = 153) or UVH (RC = 137, HTC 
= 157, and UVC = 132).   
 Heat treatment of colostrum was more effective than UVC and HTST was 
more effective than UVH in reducing bacterial counts. Immunoglobulin-G and 
lactoferrin concentrations were significantly lower in HTC and UVC than in RC. 
Lactoferrin concentrations were significantly lower in HTST than in UVH or untreated 
hospital milk. There were no significant differences in serum IgG concentrations 
among calves fed HTC, UVC or RC. Colostrum and hospital milk treatments did not 
have any significant effect on calf body weight gain, survivability, or frequency of 
diarrhea or pneumonia. 
 
 15 
INTRODUCTION 
 Colostrum provides calves with immunoglobulins (Igs), non-specific immune 
factors and nutrients (Weaver et al., 2000), but may also expose calves to pathogens 
(Stabel et al., 2004). Bacteria from contaminated colostrum may reduce the efficiency 
of IgG absorption (James et al., 1981; Johnson et al., 2007). High temperature short 
time (HTST) treatment of colostrum was associated with a decrease of 22-27% in IgG 
concentration regardless of the temperature regime (Stabel et al., 2004); however, 
when colostrum was heat treated at a lower temperature (60 °C) for 60 minutes, the 
IgG concentration did not change significantly when compared to raw colostrum 
(Johnson et al., 2007). A recent multi-herd study demonstrated similar results 
(Donahue et al., 2012). The viability of pathogens, such as Mycobacterium avium 
subsp. paratuberculosis (MAP), Escherichia coli, Listeria monocytogenes and 
Salmonella enterica serovar Enteritidis, was significantly reduced or eliminated in 
spiked colostrum after treatment at 60 °C for 60 minutes (Godden et al., 2006). 
 Feeding calves with milk replacer can be costly and the use of pasteurized, 
non-saleable milk (hospital milk) is an attractive alternative. Hospital milk includes 
milk from mastitic cows, which can have increased bacterial contamination. 
Pasteurization (63 °C for 30 minutes or 72 °C for 15 seconds) can reduce the counts of 
MAP in inoculated milk (Gao et al., 2002). On-farm pasteurization of milk effectively 
destroys MAP, Salmonella spp. and Mycoplasma spp. in spiked milk (Stabel et al., 
2004). 
 Ultraviolet (UV) light disinfection systems are commonly used for water and 
waste water treatment in the USA and Europe (Lindenauer and Darby, 1994; Guo et 
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al., 2009). Ultraviolet light destroys several pathogens in drinking water (Hijnen et al., 
2006) and Staphylococcus aureus in milk and Listeria monocytogenes in raw goat’s 
milk (Matak et al., 2005; Krishnamurthy et al., 2007;), although UV irradiation of 
milk spiked with MAP did not result in an adequate reduction in infectivity (Donaghy 
et al., 2009). 
 The aims of this study were to determine the effect of heat and UV treatment 
on (1) bacterial counts and concentrations of lactoferrin and IgG in colostrum and 
hospital milk; (2) serum IgG concentrations in calves; and (3) calf survivability, 
pneumonia, diarrhea and body weight gain in the pre-weaning period. 
 
MATERIALS AND METHODS 
Farm and Management 
 The study was conducted from February until November 2011 at a commercial 
dairy farm that milked 2,800 Holstein cows near Ithaca, New York, USA. 
Immediately after parturition, calves were removed from maternity pens and placed in 
dry sawdust bedded pens. Neonatal calves were transported twice daily from the 
maternity area to the calf barn, which was a greenhouse-type building, with eight rows 
of 40 individual pens (each 1.7 meters long and 1.2 meters wide) isolated by plastic 
panels and bedded with a deep gravel base covered with pine shavings. Calves were 
kept in the same pen until weaning. Water and calf starter were available ad libitum 
from day one until calves were moved from the calf barn to a post-weaning heifer pen. 
Calves were weaned at approximately 45 days of age by a progressive reduction in 
milk over 5 days.  
 17 
Study design and data collection 
 On the basis of a priori sample size calculations, it was estimated that, with a 
sample size of 270 calves per colostrum treatment group, an average daily weight gain 
(ADG) of 660 g (with a standard deviation of 131 g) would permit detection of 
differences in daily body weight gain ≥ 32 g. In addition, it was estimated that a 
sample size of 270 calves per colostrum treatment would permit detection of a 
difference in frequency of diarrhea of 12% between treatment groups, considering a 
baseline frequency of diarrhea of 50%. Sample size calculations were based on an α 
value of 0.05, confidence of 0.80 and a two-tailed t test. 
 A randomized field trial study design was used. All heifers born from February 
to October 2011 were eligible for enrolment in the study. All calves received 4 L 
colostrum within 4 hours of birth by esophageal tubing (Oral Calf Feeder Bag with 
Probe, Jorvet). Colostrum treatments were pre-assigned by a random table generated 
in Excel (Microsoft) using the random number function. To prepare equal aliquots of 
pooled colostrum for each of the three treatments, a minimum volume of 45 L was 
needed. Colostrum was harvested twice daily and stored in a refrigerator (1.7 °C) until 
the desired volume was reached, which was achieved within 36 hours. The pooled 
colostrum (45 L or greater) was firstly homogenized and then divided into three equal 
aliquots of at least 15 L each; one third was untreated; one third was heat treated at 63 
°C for 60 minutes using a batch pasteurizer (DT-10G Platinum, Dairy Tech) and the 
last third was treated with UV light (UV Pure system 45 J/cm
2
, GEA Farm 
Technologies). All treated colostrum was stored in 4 L containers and refrigerated (1.7 
°C) until needed. 
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 Calves were further blocked by colostrum treatment and randomized into one 
of two hospital milk treatments: HTST (72 °C for 15 seconds) or UVH (45 J/cm
2
). 
Hospital milk was harvested twice daily and stored in a stainless steel milk tank (600 
L) mounted on a transport truck and refrigerated at 5 °C until it was transported to the 
pasteurization room (located at the calf barn), where it was divided into aliquots and 
treated according to the study protocol. Calves assigned to the HTST group received 6 
L/day pasteurized hospital milk (Terminator, Goodnature Products). Calves allocated 
to the UVH group were fed 6 L/day hospital milk treated with UV light (UV Pure 
system, GEA Farm Technologies). 
 All machinery was sanitized prior to and after each running cycle. Both the 
UV-Pure system and the HTST pasteurizer are pre-set with their own clean-in-place 
procedure. The cleaning procedure comprises a pre-rinse cycle with warm water, a 
high pressure washing cycle with hot water and an alkaline detergent (TRI-PFAN, 
GEA Farm Technologies), and a final rinse with warm water and a low foam acid 
cleaner (LAC, GEA Farm Technologies). The colostrum containers (plastic jars) and 
the batch pasteurizer (DT-10G Platinum, Dairy Tech) were cleaned with an initial 
rinse with warm water, followed by a hand-brush wash using alkaline detergent, then a 
final rinse with warm water and a low-foam acid cleaner. 
 A blood sample was collected from each calf at 3 days of age; serum was 
harvested after centrifugation at 2,500 g for 10 minutes and stored at -80 °C. Birth 
weight, weekly measures of fecal scores and body weight were recorded for each calf 
until 60 days of age. 
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Case definitions 
 All health-related events during the study period were recorded. Retained 
placenta was defined as a condition where cows failed to release their fetal membranes 
within 24 hours of calving. Metritis was defined as the presence of fetid, watery, red-
brown uterine discharge. Pneumonia was defined when two or more of the following 
clinical signs were detected in a calf: cough, rectal temperature > 39.5 °C, respiratory 
rate > 40 breaths/minutes, increased cranioventral lung sounds or wheezes. Calves 
were recorded as diarrheic when the fecal consistency was watery and fetid. 
 
Microbiological assays 
 Hospital milk samples were collected before and after UVH treatment and 
HTST pasteurization twice daily for 5 days per week (January to November 2011). 
Colostrum samples were collected pre-processing (after pooling) and post-processing 
for each day (January to September 2011). Samples (50 mL) were collected, placed on 
ice and transported to the laboratory to be processed daily. Samples of colostrum and 
milk were homogenized, diluted serially (10
-1
 to 10
-12) and 20 μL aliquots were plated 
on standard aerobic medium (EMD Millipore) for total bacterial counts (TBCs), and 
on specific chromogenic media for detection and enumeration of Escherichia coli, 
Staphylococcus aureus, and group B Streptococcus spp. (CHROMagar). Plates were 
incubated aerobically for 24 hours at 37 °C. All cultures were performed in triplicate. 
The number of colony forming units (CFUs)/mL was made by calculating the average 
number of colonies (from triplicates) and multiplying this number by the appropriate 
dilution factor. 
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ELISA assay 
 To quantify immunoglobulin-G in the serum of calves and colostrum a 
commercial ELISA kit was used (Immuno-Tek Bovine IgG) and to determine 
lactoferrin in colostrum and hospital milk another commercial ELISA kit was used 
(Bethyl Laboratories). All colostrum and hospital milk samples were thawed and 
homogenized, aliquots of 1.5 mL were centrifuged at 10,000 g for 15 minutes at 4 °C, 
and the supernatant was collected and used to perform the aforementioned assays. 
 
Statistical analysis 
 Descriptive statistics and univariable analysis were performed using SAS. 
Analysis of variance (ANOVA) was used to evaluate the effect of hospital milk and 
colostrum treatments on the log reduction of CFU and the effect of colostrum 
treatment (RC, HTC or UVC) on IgG and lactoferrin concentrations using the MIXED 
procedure in SAS. 
 To analyze the effect of colostrum treatment on calf serum IgG concentrations 
at 3 days of life, a general linear model was fitted to the data using SAS. The outcome 
variable was calf serum (g/L), which was modelled as a Gaussian (normally 
distributed data) variable. The model assumption that the residuals were normally 
distributed was assessed and satisfied by visual evaluation of the distribution plot of 
the Studentized residuals. Other independent variables offered to the model were 
parity of the dam (primiparous or multiparous), location of parturition (maternity pen 
or pre-fresh free stall - where dry cows were housed during 3 week before expected 
calving date), calving ease of the dam (assisted or non-assisted), gestation length of 
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the dam (days), birth weight quartile, and dam postpartum health events (metritis, 
displaced abomasum and retained placenta).  
 The only calf-related risk factors offered to the models were those observed 
before enrolment (e.g. post-treatment colostrum bacterial CFU was not offered). 
However, post-parturition dam-related risk factors, such as postpartum diseases, were 
included in the regression models. All possible two-way interaction terms between 
treatments and all independent variables were evaluated in the model. Manual 
backward variable elimination considering main effects and two-way interactions of 
colostrum treatment with all the other independent variables was performed. Variables 
and interaction terms were retained in the model when P ≤ 0.05.  
 The effect of treatment on calf survival was analyzed by Cox’s proportional 
hazard model in SAS. Calves were right-censored if they were alive at the end of the 
data collection period (60 days). Variables offered to the models included colostrum 
treatment (RC, UVC or HTC), hospital milk treatment group (UVH or HTST), parity 
of the dam (primiparous or multiparous), calving location (maternity pen or pre-fresh 
free stall), calving ease of the dam (assisted or non-assisted), gestation length (days), 
dam post-partum health events (metritis, displaced abomasum and retained placenta) 
and calf birth weight quartiles (first: 22 to 37 kg; second: 38 to 41 kg; third: 39 to 44 
kg; fourth: 45 to 59 kg). All possible two-way interaction terms between treatments 
and all independent variables were evaluated in the model, as well as the two-way 
interaction between colostrum and waste milk treatment. Backward variable 
elimination (Cantor, 1997) was undertaken considering main effects and two-way 
interactions of colostrum and waste treatment with all the other independent variables. 
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Variables and interaction terms were retained in the model when P ≤ 0.05. 
 The effects of colostrum and hospital milk treatments on diarrhea and 
pneumonia were evaluated by logistic regression models that were fitted in Stata 
(StataCorp LP); the dependent variables for these models were occurrence of diarrhea 
or pneumonia (no = 0 or yes = 1) over the entire observation period (60 days). The 
independent variables offered to this model were the same as described above for the 
other multivariable models. Interaction terms and variable selection methodology were 
evaluated as described for the Cox’s Proportional Hazard model. Adjusted 
probabilities were calculated from the model for all categorical variables retained in 
the model using the adjusted probability option in Stata. 
 A mixed general linear model was fitted to the data using SAS software to 
analyze the effect of colostrum and hospital milk treatment groups on repeated 
measures of calf ADG per week. Calf daily weight gain was calculated for each week 
by subtracting the latest body weight from the previous week’s body weight and 
dividing it by seven; therefore, the outcome variable was a series ADG, which was 
modeled as a Gaussian (normally distributed data) variable. The assumption that the 
residuals were normally distributed was assessed by visually evaluating the 
distribution plot of the Studentized residuals. The independent variables offered to the 
model were colostrum treatment group (RC, UVC or HTC), hospital milk treatment 
group (UVH or HTST), week since birth (0 to 8 weeks), parity of the dam 
(primiparous or multiparous), gestation length of the dam (days), calving location 
(maternity pen or pre-fresh free stall) and dam post-partum health events (metritis, 
displaced abomasum, and retained placenta). The only calf related risk factors offered 
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to the models were those observed before enrolment (e.g. post-treatment colostrum 
bacterial CFU was not offered). However, post-parturition dam-related risk factors, 
such as postpartum diseases, were included. 
 The calf daily weight gains were collected longitudinally and consisted of a 
total of eight measurements per calf; the first calf weight measurement was collected 
within 12 hours of birth and subsequently eight other weekly measurements were 
collected until weaning. Since weight measurements were repeated measures within 
each calf, the error term was modeled by imposing a first order autoregressive 
covariance structure to appropriately account for within-calf correlation. All possible 
two-way interaction terms between treatments and all independent variables were 
evaluated in the model, as well as the two-way interaction between colostrum and 
waste milk treatment. Backward variable elimination considering main effects and 
two-way interactions of colostrum and waste treatment with all the other independent 
variables was performed. Variables and interaction terms were retained in the model 
when P ≤ 0.05. A separate model, similar to the model described above, was used to 
evaluate the effect of calf diseases on weekly weight gain. For all general linear 
models and mixed general linear models, the least square means (LSM) are reported. 
 
RESULTS 
Descriptive statistics 
 Descriptive statistics for calf- and dam-related events are presented in Table 
1.1. 
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Bacteriology, IgG and lactoferrin concentrations in colostrum and hospital milk 
 Log reductions in CFUs were significantly lower in HTC than UVC for TBCs, 
Escherichia coli, and Streptococcus spp. There was no difference between HTC and 
UVC in the CFU log reduction values for S. aureus. Colony forming units for total 
bacteria count were significantly lower in HTST than UVH (P < 0.01). There was no 
significant difference between UVH and HTST in CFU log reduction values for 
Escherichia coli and Streptococcus spp. (P = 0.88; Table 1.2). For Staphylococcus 
aureus, cultures only identify S. aureus during the months of March and April. 
 There were significantly lower IgG concentrations in HTC (52.4 g/L; 95% 
confidence interval, CI, 48-57 g/L) and UVC (39.5 g/L; 95% CI 35-44 g/L) compared 
to RC (69.1 g/L; 95% CI 64-74 g/L; P < 0.001; Figure 1.1).
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Table 1.1: Descriptive statistics for calf and dam related events by treatment groups. Ultraviolet light treatment of colostrum 
(UVC), heat treatment of colostrum (HTC), ultraviolet light treatment of hospital milk (UVH) and high temperature, short time 
pasteurization of hospital milk (HTST). 
 
 
RC UVC HTC 
UVH HTST UVH HTST UVH HTST 
n 137 144 132 153 157 152 
Calves born to multiparous cows, % 57% 56% 50% 58% 50% 55% 
Calves born to assisted parturition, % 6% 12% 10% 13% 8% 8% 
Calves born in the free-stall, % 18% 17% 20% 18% 15% 17% 
Calf diarrhea, % 41% 43% 34% 42% 36% 34% 
Calf pneumonia, % 14% 11% 10% 8% 8% 9% 
Calf mortality, % 6% 3% 4% 4% 4% 5% 
Calf morbidity, % 92% 94% 93% 95% 96% 93% 
Dam diagnosed with retained placenta, % 4% 6% 4% 4% 6% 3% 
Dam diagnosed with metritis, % 16% 10% 11% 12% 17% 9% 
Dam diagnosed with displaced abomasum, % 2% 1% 2% 1% 3% 2% 
Calves’ birth weight, kg 41.6 (5.2) 42.4 (5.7) 42.5 (5.8) 42.2 (5.5) 41.5 (5.7) 41.0 (5.0) 
Calves’ serum immunoglobulin-G, g/L 22.2 (1.3) 23.0 (1.7) 20.2 (1.2) 20.2 (1.3) 23.0 (1.3) 23.3 (1.2) 
Gestation length, days 276 (6.1) 276 (6.3) 276 (6.3) 276 (7.0) 276 (4.9) 277 (4.2) 
Average daily weight gain, g/day 677 (53) 683 (55) 685 (63) 669 (61) 664 (53) 690 (53) 
Pre-treatment milk, 
CFU/mL 
TBC 17 x 10
6
 14 x 10
6
 17 x 10
6
 16 x 10
6
 15 x 10
6
 15 x 10
6
 
Escherichia coli 11 x 10
6
 9.4 x 10
6
 9.9 x 10
6
 9.3 x 10
6
 7.6 x 10
6
 15 x 10
6
 
Streptococcus spp.  7.8 x 10
5
 9.1 x 10
5
 7.9 x 10
5
 8.2 x 10
5
 8.8 x 10
5
 10 x 10
6
 
TBC, Total bacteria count for enumeration of total aerobic bacteria using standard medium 
Escherichia coli, Detection and enumeration of Escherichia coli using chromogenic medium 
Streptococcus spp., Detection and enumeration of group B Streptococcus spp. using chromogenic medium 
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Table 1.2: Average log reductions in bacterial colony counts for ultraviolet light 
treatment of colostrum (UVC), heat treatment of colostrum (HTC), ultraviolet light 
treatment of hospital milk (UVH) and high temperature, short time pasteurization of 
hospital milk (HTST). 
 
 Mean (SD)
 
 Colostrum (n = 297) Hospital Milk (n=712) 
 UVC
 
HTC
 
UVH
 
HTST
 
TBC  1.7 (1.0)
 a
 3.5 (1.5)
 b
 3.3 (1.8) 
a
 5.2 (1.1) 
b
 
Escherichia coli 
 
2.2 (1.9) 
a
 4.5 (2.7) 
b
 1.7 (1.7) 
a
 1.2 (1.8) 
a
 
Staphylococcus aureus  0.4 (1.2) 
a
 0.4 (1.2) 
a
 0.2 (0.8) 
a
 0.2 (0.8) 
a
 
Streptococcus spp. 
 
2.5 (1.9) 
a
 2.5 (1.9) 
a
 2.0 (2.2) 
a
 2.4 (2.3) 
a
 
a,b, Different letters within the same column indicate statistically significant differences 
(P<0.05). 
UVC, Ultraviolet light colostrum treatment 
HTC, Heat treatment of colostrum (63 °C for 60 minutes) 
UVH, Ultraviolet light hospital milk treatment 
HTST, High temperature short time pasteurization of hospital milk (72 °C for 15 seconds) 
Mean (SD), Mean post-treatment colony forming unit log reduction and standard 
deviation 
TBC, Total bacteria count for enumeration of total aerobic bacteria using standard 
medium 
Escherichia coli, Detection and enumeration of Escherichia coli using chromogenic 
medium 
Staphylococcus aureus, Detection and enumeration of Staphylococcus aureus using 
chromogenic medium 
Streptococcus spp., Detection and enumeration of group B Streptococcus spp. using 
chromogenic medium 
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Figure 1.1: Average colostrum IgG and respective 95% confidence intervals by the 
different treatment groups. Raw colostrum (pre-process; RC), ultraviolet light 
treatment of colostrum (UVC), and heat treatment of colostrum (63 °C for 60 minutes; 
HTC). The average colostrum Immunoglobulin-G was 69.1 mg/mL (95% CI, 64-74 
g/L), 52.4 mg/mL (48 – 57), and 39.5 mg/mL (35 – 44) for RC (n= 91), HTC (n = 94), 
and UVC (n = 96) respectively (P < 0.001). (52.4 g/L; 95% confidence interval, CI, 
48-57 g/L) and UVC (39.5 g/L; 95% CI 35-44 g/L) compared to RC (69.1 g/L;; P < 
0.001 
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Concentrations of lactoferrin were significantly lower in HTC and UVC than RC (P < 
0.001) and in HTST compared to untreated hospital milk (P < 0.01), whereas there 
was no significant difference between UVH and untreated hospital milk (P = 0.22; 
Figure 1.2).  
 
  
 
Figure 1.2: Average lactoferrin concentration and respective 95% confidence 
intervals by the different treatment groups. Raw colostrum (RC), ultraviolet light 
treated colostrum (UVC), and heat treated colostrum (63 °C for 60 minutes; HTC). 
Lactoferrin was also measured in fresh hospital milk (Fresh), ultraviolet treated 
hospital milk (UVH), and pasteurized hospital milk (HTST). 
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Serum IgG, disease, survivability and average daily gain of calves  
 There were no significant differences in serum IgG concentrations at 3 days of 
life between calves fed HTC, UVC or RC (P = 0.1; Table 1.3). 
 
Table 1.3: Least squares means (LSMs) of calf serum immunoglobulin G (g/L) by 
categorical variables included in the analysis of variance (ANOVA).  
 
  
Regression 
Coefficient (± SE) 
LSM
 
(95% CI) of 
serum IgG (g/L) 
P-value 
Intercept  21.98 (1.26)   
Treatment
 
RC
 
Reference 22.5 (20.7-24.4) 
0.1 HTC
 
0.58 (1.28) 23.1 (21.4-24.8) 
UVC
 
-2.02 (1.31) 20.5 (18.7-22.3) 
Birth weight 
quartiles, kg 
22 to 37 -2.23 (1.44) 19.3 (17.3-21.3) 
0.006 
38 to 41 1.99 (1.48) 23.5 (21.4-25.6) 
42 to 44 2.46 (1.49) 23.9 (21.9-26.1) 
45 to 59 Reference 21.5 (19.5-23.5) 
RC, Raw colostrum 
HTC, Heat treatment of colostrum (63 °C for 60 minutes) 
UVC, Ultraviolet-light treatment of colostrum 
 
 
 The variables colostrum and hospital milk treatments were not significantly 
associated with the odds of diarrhea or pneumonia. Parity of the dam, parturition 
assistance and birth weight quartile were significantly associated with the odds of 
diarrhea; calves in the smallest birth weight quartile had the highest odds of diarrhea, 
with an adjusted diarrhea frequency of 46% compared to an adjusted frequency of 
35.7% for the calves in the highest birth weight quartile (P = 0.01; Table 1.4).  
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Table 1.4: Effect of colostrum and hospital milk treatments on the odds of diarrhea 
analyzed by multivariable logistic regression.  
 
  
Regression 
Coefficient  
(± SE) 
Adjusted 
Probability 
% 
Adjusted 
Odds Ratio 
(95% CI) 
P-value 
Intercept  -0.31 (0.12)    
Colostrum  
RC Reference 42.8 Reference 
0.17 HTC -0.14 (0.1) 36.7 0.7 (0.5-1.0) 
UVC -0.03 (0.1) 40.2 0.8 (0.6-1.1) 
Hospital milk  
HTST Reference 38.6 Reference 
0.82 
UVH -0.02 (0.07) 37.1 1.0 (0.7-1.3) 
Calving 
Natural Reference 37.0 Reference 
0.05 
Assisted 0.23 (0.12) 46.3 1.6 (1.0-2.5) 
Dam’s Parity  
Primiparous Reference 32.1 Reference 
0.001 
Multiparous 0.24 (0.07) 43.2 1.6 (1.2-2.2) 
Birth weight 
quartiles, kg 
22-37 0.28 (0.12) 46.0 1.8 (1.2-2.4) 
0.01 
38-41 0.15 (0.12) 44.5 1.6 (1.1-2.4) 
42-44 -0.1 (0.13) 40.1 1.3 (0.8-1.9) 
45-59 Reference 35.7 Reference 
RC, Raw colostrum 
HTC, Heat treatment of colostrum (63 °C for 60 minutes) 
UVC, Ultraviolet-light treatment of colostrum 
HTST, High temperature short time pasteurization of hospital milk (72 °C for 15 seconds) 
UVH, Ultraviolet-light treatment of hospital milk 
  
 Calves born to cows that developed metritis had 1.9 times higher likelihood of 
having pneumonia compared to calves born from cows that did not develop metritis (P 
= 0.04; Table 1.5). 
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Table 1.5: Effect of colostrum and hospital milk treatments on the odds of pneumonia 
analyzed by multivariable logistic regression. 
 
  
Regression 
Coefficient 
(± SE) 
Adjusted 
Probability 
% 
Adjusted 
Odds Ratio 
(95% CI) 
P-value 
Intercept  -1.43 (0.18)    
Colostrum 
RC Reference 12.3 Reference 
0.37 HTC -0.16 (0.17) 8.6 0.68 (0.4-1.3) 
UVC -0.05 (0.17) 9.0 0.76 (0.4-1.3) 
Hospital milk 
HTST Reference 9.2 Reference 
0.54 
UVH 0.07 (0.12) 10.7 1.1 (0.7-1.8) 
Metritis 
No Reference 8.4 Reference 
0.04 
Yes 0.32 (0.16) 20.9 1.9 (1.0-3.5) 
Retained Placenta 
No Reference 8.5 Reference 
0.001 
Yes 0.73 (0.19) 36.4 4.3 (2.1-9.0) 
Dam’s parity 
Primiparous Reference 7.2 Reference 
0.07 
Multiparous 0.22 (0.12) 12.3 1.6 (1.0-1.8) 
RC, Raw colostrum 
HTC, Heat treatment of colostrum (63 °C for 60 minutes) 
UVC, Ultraviolet-light treatment of colostrum 
HTST, High temperature short time pasteurization of hospital milk (72 °C for 15 seconds) 
UVH, Ultraviolet-light treatment of hospital milk 
 
 
 The variables colostrum and hospital milk treatment were not significantly 
associated with survivability. The independent variables parity of the dam, metritis of 
the dam and birth weight ‘quartiles’ were significantly associated with survivability 
(Table 1.6).  
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Table 1.6: Cox’s proportional hazards survival analysis evaluating the effect of 
different risk factors on calf survival during the first 60 days of life (from birth until 
60 days). 
 
  
Regression 
coefficient 
(±SE) 
Mortality 
% 
Hazard Ratio 
(95% CI) 
P-value 
Colostrum  
RC
 
Reference 3.2 Reference 
0.890 HTC
 
0.09 (0.45) 3.8 1.1 (0.4-2.6) 
UVC
 
-0.14 (0.49) 2.8 0.87 (0.3-2.3) 
Hospital milk  
HTST
 
Reference 2.4 Reference 
0.178 
UVH
 
0.53 (0.39) 4.2 1.7 (0.8-3.6) 
Dam’s parity 
Primiparous Reference 1.9 Reference 
0.015 
Multiparous 1.04 (0.43) 4.4 2.8 (1.2-6.5) 
Metritis 
No Reference 2.4 Reference 
0.004 
Yes 1.14 (0.41) 9.5 3.2 (1.4-7.2) 
Birth weight 
quartiles, kg 
22-37 1.23 (0.49) 6.5 3.4 (1.3-9.0) 
0.008 
38-41 -0.73 (0.82) 1.4 0.5 (0.1-2.4) 
42-44 0.30 (0.61) 2.6 1.3 (0.4-4.4) 
45-59 Reference 2.3 Reference 
RC, Raw colostrum 
HTC, Heat treatment of colostrum (63 °C for 60 minutes) 
UVC, Ultraviolet-light treatment of colostrum 
HTST, High temperature short time pasteurization of hospital milk (72 °C for 15 seconds) 
UVH, Ultraviolet-light treatment of hospital milk 
 
 
 The variables colostrum and hospital milk treatment were not significantly 
associated with ADG. There was a significant association between pneumonia and 
ADG (Table 1.7).  
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Table 1.7: Effect of colostrum and hospital milk treatments, birth weight, pneumonia 
and calving location on average daily weight gain (ADG). Average daily weight gain 
(g) was calculated for each week. Weight was measured weekly from birth until 
weaning for a total of 8 weeks. 
 
  Regression coefficient    
(±SE) 
Adjusted ADG         
(95% CI) 
P-value 
Intercept  795.5 (55.1)   
Birth weight  -3.25 (1.2)  0.01 
Colostrum  
RC Reference 617.7 (582.8-652.6) 
0.92 HTC -6.3 (16.1) 611.4 (577.2-645.7) 
UVC -4.2 (16.3) 613.5 (578.4-648.6) 
Hospital milk  
HTST Reference 613.9 (581.5-646.4) 
0.96 
UVH 0.58 (13.1) 614.5 (582.5-646.5) 
Pneumonia 
No Reference 676.0 (655.3-696.7) 
0.0001 
Yes -123.6 (25.0) 552.4 (502.2-602.7) 
Calving 
location 
Stall Reference 594.3 (550.0-638.7) 
0.06 
Maternity  39.8 (20.8) 634.1 (609.3-659.0) 
RC, Raw colostrum 
HTC, Heat treatment of colostrum (63 °C for 60 minutes) 
UVC, Ultraviolet-light treatment of colostrum 
HTST, High temperature short time pasteurization of hospital milk (72 °C for 15 seconds) 
UVH, Ultraviolet-light treatment of hospital milk 
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DISCUSSION 
 In this study, UV and heat treatments reduced CFU counts in colostrum and 
hospital milk. Heat treatment was generally more effective than UV treatment in 
decreasing bacteria counts in colostrum and hospital milk. HTC had lower TBCs and 
CFU counts for E. coli and Streptococcus spp., but not for S. aureus, than UVC. HTST 
had lower TBCs than UVH treatment, but there was no difference in CFU counts for 
E. coli and Streptococcus spp. between HTST and UVH. 
 Heat treatment of colostrum and HTST of hospital milk have been evaluated 
extensively as means to reduce bacterial contamination of colostrum and milk and, 
consequently, disease incidence in calves (Meylan et al., 1996; Grant et al., 2002; 
Stabel et al., 2004; Elizondo-Salazar et al., 2010; Donahue et al., 2012; Godden et al., 
2012; Pearce et al., 2012). Our results are largely in agreement with the published 
literature and illustrate the high efficiency of HTC and HTST in reducing TBC and 
CFU counts for E. coli, S. aureus, and Streptococcus spp. UV light treatment of goats’ 
milk reduces L. monocytogenes counts (Matak et al., 2005). No studies have been 
published that evaluate UV treatment of waste milk, specifically colostrum. 
 The composition and consistency of a liquid can affect UV light penetration 
and its bactericidal activity (Foley and Otterby, 1978; Lindenauer and Darby, 1994). 
The presence of dissolved and suspended solids can scatter UV light and provide a site 
for bacterial aggregation, attenuating the bactericidal activity of this form of radiation 
(Ye et al., 2007; Koutchma et al., 2004). Colostrum has a thicker consistency than 
hospital milk and higher percentages of total solids (23.9 vs. 12.9%), fat (6.7 vs. 4.0%) 
and protein (14.0 vs. 3.1%; Godden, 2008). Therefore, UV light penetration and the 
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rate of bacterial inactivation would be expected to be lower in colostrum than hospital 
milk. In our study, a direct comparison between UVC and UVH was not possible, 
since colostrum and hospital milk samples had different initial bacterial counts. 
Nevertheless, when evaluating the log reductions of bacterial counts in UVC vs. HTC 
and UVH vs. HTST, UV light appeared to be more effective in reducing bacterial 
counts in hospital milk than in colostrum. 
 HTC and UVC significantly decreased colostrum IgG concentrations 
compared to untreated colostrum, with mean IgG reductions of 24.2% and 42.8%, 
respectively. This finding is consistent with reported losses of 23.6-58.8% for a 
standard LTLT pasteurization protocol (63 °C for 30 minutes) (Godden et al., 2003). 
A reduction of 12.3% in colostrum IgG concentration was reported using a laboratory 
simulation of the LTLT method (63 °C for 30 minutes) (Meylan et al., 1996). Using a 
lower temperature (60 °C) for a longer period of time (60 minutes), there was no 
significant reduction in IgG concentrations in heat treated colostrum compared to raw 
colostrum (Donahue et al., 2012). Interestingly, ultraviolet light treatment of 
colostrum resulted in significantly lower IgG concentrations than in raw or heat-
treated colostrum. The authors could not identify in the literature a possible 
justification for this reduction and further work to elucidate the mechanism for this 
effect is warranted. 
 In the present study, there were no significant differences in serum IgG 
concentrations at 3 days of life among calves fed HTC, RC or UVC. In an earlier 
study by Godden et al. (2003), calves fed 4 L of LTLT-treated colostrum (63 °C for 30 
minutes) had no differences in serum IgG concentrations in comparison with calves 
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fed untreated colostrum. In a study by Johnson et al. (2007), colostrum treated at 60 
°C for 60 minutes had reduced concentrations of bacteria compared to untreated 
colostrum, without a reduction in IgG concentrations; furthermore, calves fed heat 
treated colostrum had significantly higher serum IgG and total protein concentrations 
than calves fed raw colostrum. 
 James et al. (1981) reported a reduced uptake of γ-globulin when segments of 
calf intestine were exposed to bacteria when compared to calves receiving sterile 
inoculum. In our study, UV light treatment was less effective than heat treatment in 
reducing TBC and also resulted in a greater reduction in colostrum IgG concentration; 
however there was no significant difference in serum IgG concentrations in calves fed 
UV-treated, heat treated or untreated colostrum. 
 Lactoferrin binds and sequesters iron, acting as a bacteriostatic protein 
(Miyauchi et al., 1998; Baker and Baker, 2005). In a study by Joslin et al. (2002), 
calves fed milk replacer supplemented with lactoferrin (1 g/day) during the pre-
weaning period had significant higher ADG than non-supplemented calves. In the 
present study, lactoferrin concentrations were decreased in heat and UV treated 
colostrum compared to RC. Pasteurization of hospital milk (HTST) is known to reduce 
concentrations of lactoferrin (Schwarcz et al., 2008). In this study HTST was 
associated with a significant reduction in lactoferrin concentrations. However, UVH 
did not significantly reduce lactoferrin concentrations in hospital milk. 
 Colostrum and hospital milk treatments did not affect the incidence of 
diarrhea. However, the parity of the dam, assisted parturition, and calf birth weight 
were significantly associated with calf diarrhea during the pre-weaning period. There 
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was a negative correlation between calves born from multiparous cows and the 
frequency of diarrhea. In contrast, an observational study by Perez et al. (1990), in 
which calves were fed their own mothers’ colostrum, calves born from primiparous 
cows had an increased risk of developing diarrhea. In the present study, calves born 
from assisted parturitions were more susceptible to diarrhea during the pre-weaning 
period. In contrast, Sivula et al. (1996) and Lombard et al. (2007) reported a negative 
effect of assisted parturitions on the incidence of calf diarrhea in earlier life when 
compared to calves born from normal calving. 
 In this study, colostrum and hospital milk treatments did not affect the 
incidence of pneumonia. However, calves born from cows that subsequently 
developed metritis or retained placenta were more likely to have pneumonia up to 60 
days of life. Parity of the dam was not associated with incidence of pneumonia. 
However, Perez et al. (1990) reported that calves born from primiparous cows were 
less prone to pneumonia. In a study by Lombard et al. (2007), calves born to 
primiparous cows had a reduced likelihood of a respiratory event compared to calves 
born to multiparous cows. Calves born to cows that had a disease 280-50 days before 
calving or cows with retained placenta at parturition were at a higher risk of 
developing pneumonia than were calves born to healthy cows (Lundborg et al., 2003). 
 The ADG of calves with pneumonia was 124 g/day less than unaffected calves 
and they were on average 5 kg lighter at weaning. Similarly, Virtala et al. (1996) 
reported that calves treated for pneumonia had a reduction of 66 g/day in ADG. 
Lundborg et al. (2003) also reported a negative effect of respiratory disease on calf 
growth. 
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 Survivability of calves was affected by parity of the dam, birth weight of the 
calf and metritis of the dam, but was not affected by colostrum or hospital milk 
treatment. Calves with a birth weight of 38-41 kg were less likely to die before 
weaning. Similarly, Henderson et al. (2011), observed that an ‘arrival weight’ (weight 
recorded within 2 days of birth for calves entering rearing facilities) of 38-41 kg was 
optimal for calf survivability. In the present study, calves born from cows that 
developed metritis were more susceptible to pneumonia and this could be the reason 
why metritis of the dam was also associated with calf survivability. 
 There were no significant differences on calf health and growth between 
colostrum and hospital milk treatments, but larger group sizes would require exploring 
these associations further. 
 
CONCLUSIONS 
 Heat treatment of colostrum and hospital milk was more effective than UV 
treatment in decreasing bacterial counts. Colostral IgG concentrations were 
significantly reduced by heat and UV treatment. Lactoferrin concentrations were 
significantly reduced in treated colostrum, but not in UV treated hospital milk. 
Colostrum and hospital milk treatments were not associated with calf survivability, 
diarrhea, pneumonia or body weight gain. Parity, metritis of the dam, and calf birth 
weight were significantly associated with calf survivability. Parity, calf birth weight, 
and parturition assistance were significantly associated with the incidence of diarrhea. 
Metritis and retained placenta of the dam were significantly associated with calf 
pneumonia. 
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ABSTRACT 
 The objective of this study was to evaluate the effect of 2 subcutaneous 
injections of a multimineral preparation, each containing 60 mg of zinc, 10 mg of 
manganese, 5 mg of selenium, and 15 mg of copper at 3 and 30 d after birth on 
immunity, health, and growth of dairy calves during the pre-weaning period. The 
study was conducted in upstate New York in 2 commercial dairy farms. A total of 790 
Holstein heifer calves were randomly allocated at birth into 1 of 2 treatments: trace 
mineral supplement (TMS) treated or control. Blood samples were collected at 3, 14, 
and 35 d after birth to evaluate glutathione peroxidase (GPx) activity, super- oxide 
dismutase (SOD) activity, haptoglobin, and neutrophil and monocyte function. 
Incidence of diseases and average daily gain was evaluated in the first 50 d of life. At 
14 d of life, TMS-treated calves had increased neutrophil activity compared with 
control calves. Moreover, TMS-treated calves had greater GPx activity on d 14 after 
birth than control calves. 
 The TMS treatment reduced the incidence of diarrhea (TMS = 41.7% vs. 
control = 49.7%) and combined incidence of pneumonia or otitis or both (TMS = 
41.7% vs. control = 49.1%). Additionally, GPx was greater for calves diagnosed with 
otitis at d 35 after birth. However, calves diagnosed with pneumonia had decreased 
GPx activity at d 35 after birth. Serum SOD and haptoglobin concentrations were not 
affected by treatment or disease. More- over, no effects were observed on average 
daily gain and survivability between TMS-treated and control calves during the pre-
weaning period. Supplementation with trace minerals at 3 and 30 d of life increased 
neutrophil function and GPx activity and reduced the incidence of health disorders.  
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INTRODUCTION 
 Dairy replacement rearing success or failure is de- pendent on several complex 
and interrelated factors. Newborn calf health and growth can be impaired by poor 
maternal health (Lundborg et al., 2003), dystocia (Lombard et al., 2007), colostrum 
deprivation (Weaver et al., 2000), and poor calf nutrition (Ollivett et al., 2012). In the 
modern dairy industry, calves are reared artificially and early nutritional programs 
have been extensively studied to improve their performance during the pre-weaning 
period (Soberon et al., 2012). The physiological processes of a livestock animal,  
including the immune system, can be largely influenced by the availability of nutrient 
and trace minerals that are essential for multiple biochemical processes, including 
immune response, cell replication, and skeletal development, and are particularly 
relevant for the newborn (Carroll and Forsberg,  2007). 
 Studies that evaluate trace mineral depletion or supplementation focus on 
critical times in calves’ lives and evaluate the effects of factors such as 
transportation (Crookshank et al., 1979), stress (Galyean et al., 1999), and diseases 
(Orr et al., 1990). For adult cattle, stress during the transition period can affect trace 
mineral status (zinc) and immune suppression can lead to greater susceptibility to 
diseases (Enjalbert et al., 2006). Likewise, stress can affect trace mineral status   in 
dairy calves. Nockels et al. (1993) reported that calves under induced stress 
(intramuscular injections of ACTH) reduced their ability to retain trace minerals. 
An injectable trace mineral solution containing Zn, Cu, Mn, and Se was reported to 
increase liver concentrations of Cu and Se for at least a 15-d period, and increased 
plasma Zn and Mn for several hours in Angus and Simmental steers (Pogge et al., 
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2012). 
 Metabolic demands associated with stress and nutritional deficiency can lead 
to an increased production of reactive oxygen species (ROS; Sordillo and Aitken, 
2009). When the production of ROS exceeds the antioxidant defense mechanisms 
present in the body, animals develop oxidative stress. Reactive oxygen species can 
initiate lipid peroxidation and cause cellular dam- age to tissues. Immune cells are 
particularly sensitive to oxidative stress because their membranes contain high 
concentrations of PUFA that are very susceptible to peroxidation, and produce large 
amounts of ROS when stimulated (Spears and Weiss, 2008). Several trace minerals 
are required for functioning of enzymes involved in the antioxidant defense system 
and may also affect immune cells via mechanisms distinct from antioxidant 
properties (Spears, 2000). 
 The role of early postnatal supplementation with injectable trace minerals on 
the immune response of new- born calves has not been investigated. Therefore, the 
objectives of this study were to evaluate the effect of supplementation of an 
injectable multimineral supplement containing Zn, Mn, Se, and Cu at 3 and 30 d after 
birth on peripheral blood neutrophil and lymphocyte function, oxidative stress 
markers, diseases (diarrhea, pneumonia, and otitis), and growth of Holstein heifer 
calves during the pre-weaning period. 
 
 48 
MATERIALS AND METHODS 
Farm, management, housing and feeding 
The study was conducted in 2 commercial dairy farms located near Ithaca, 
New York, from February until December of 2012. Farms were chosen because of 
their relationship with Cornell University - Ambulatory Clinic. Farm A was milking 
approximately 2,800 cows and their calf rearing program was composed by two 
housing and feeding systems (group-pens fed ad libitum acidified non-sealable milk, 
and individual-pens fed pasteurized non-sealable milk). Farm B was milking 
approximately 1,600 cows and their calf rearing program was constituted of one 
housing type and feeding system with individual-pens fed pasteurized non-sealable 
milk.  
 Colostrum management was similar in both farms. Colostrum from 
primiparous and multiparous cows was pooled and refrigerated. Calves from farm A 
were fed approximately 4 L of raw colostrum within 4 h of birth at once by esophageal 
feeder (Oral Calf Feeder Bag with Probe, Jorvet). Calves from farm B were fed 2 L of 
raw colostrum within 2 hours and another 2 L approximately 6 hours later. 
In farm A, calves were transported twice daily from the maternity area into two 
adjacent green-house type barn using two different rearing systems; group-pens and 
individual-pens. Group housing (n = 446) system was comprised of 15 group-pens for 
20 calves. The group-pens of 70 square meters each were straw bedded on the top of a 
thin layer of dry composted manure. The barn was positive-pressure ventilated; pens 
were separated by stainless-steel gates. Calves were nipple-fed ad libitum acidified 
(Formic Acid 10% AgroChem Inc.) non-sealable milk (4.5 pH) until weaning (45 ± 5 
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d) based on milk reduction for 7 days. 
Farm A (n = 194) and B (n = 150) had similar individual-pens set-ups in a 
green-house type barn, positive-ventilated comprised of 4 rows of 35 individual-pens; 
pens were 1.5 meter wide by 2 meter long isolated by flat plastic panels within each 
other bedded with a 0.5 meter deep gravel base that was covered with straw. Farm A 
and B had the same feeding system for calves allocated in individual-pens; each 
individual pen was provided with two 5 L plastic bucket; calves were fed a total of 6 L 
of pasteurized (72
o
C for 15 seconds; T-600 and T-300 GoodNature Products Inc.) non-
saleable milk divided equally twice a day; 0630h and 1700h. The same bucket was 
cleaned (manually using hot water with chlorinated detergent, followed by a warm 
rinse with water) and filled with water after each feeding; the second bucket was 
always filled with calf starter (starter composition Table 2.1). Calves were weaned at 
45 (±5) days based on milk reduction for 7 days. 
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Table 2.1: Nutrient composition of calf starter diets for farms A and B. 
 
 
Starter Diet 
Composition Farm A Farm B 
Dry Matter (%) 82.1 90.9 
Crude Protein (% of  DM) 19.8 22.9 
Neutral Detergent Fiber (% of DM) 29.4 31.8 
Acid Detergent Fiber (% of  DM) 15.7 14.1 
Total Digestible Nutrients (% of DM) 72 77 
Calcium (% of DM) 0.99 0.94 
Phosphorus (% of DM) 0.64 0.78 
Magnesium (% of DM) 0.43 0.35 
Potassium (% of DM) 1.4 1.01 
Sodium (% of DM) 0.35 0.39 
Sulfur (% of DM) 1.28 0.35 
Iron (mg/kg) 398 258 
Zinc (mg/kg) 65 111 
Copper (mg/kg) 20 22 
Manganese (mg/kg) 66 100 
  
Study design, treatments, blood sampling and data collection 
 A total of 790 calves were randomly allocated into the 2 treatments:  trace 
mineral supplement (TMS) treatment or control. Randomization was completed using 
the random number function in Excel software (Microsoft Corp., Redmond, WA).  
Calves allocated into the TMS treatment received two 1-mL subcutaneous injections 
(60 mg of Zn, 10 mg of Mn, 5 mg of Se, and 15 mg of Cu; Multimin North America 
Inc., Fort Collins, CO) at 3 and 30 d after birth. Calves allocated into the control group 
were left untreated. Body weight was measured weekly in both farms using a WayPig  
15, 1.6-m (62-inch) digital scale (WayPig; Vittetoe Inc., Keota, IA) from birth until 
weaning, which occurred at 50 d of  life. 
 Blood collection was performed via jugular venipuncture using an 18-gauge by 
3.8-cm needle in 2 individual vacuum tubes: a 10-mL vacuum tube (Becton, 
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Dickinson and Co., Franklin Lakes) without anticoagulant for serum and an 8-mL 
heparinized vacuum tube (Becton, Dickinson and Co.) for plasma. Serum was 
harvested following centrifugation at 2,000 × g for 15 min at 4°C and plasma was 
harvested after centrifugation at 1,000 × g for 10 min at 4°C. Serum and plasma 
samples were stored at −80°C. Blood was sampled on d 3 (immediately before 
treatment administration), 14, and 35 after birth to evaluate glutathione peroxidase 
(GPx), superoxide dismutase (SOD), and haptoglobin (Hp). Additionally, serum IgG 
concentration was measured only on d 3. 
 A random subset of serum samples from 10 calves (5 for treatment) were sent 
to Veterinary Diagnostic Laboratory, Iowa  State University (Ames) for analysis  of 
Ca, Cu, Fe, K, Mg, Mn, Mo  P,  Se,  and  Zn.  Blood mineral levels were measured at 
3, 14, and 35 d after birth. The concentrations of serum trace elements were analyzed 
by an inductively coupled plasma mass spectrometry (ICP-MS) system (Varian/Bruker 
820 ICP-MS; Bruker Corp., Fremont, CA) through separation of analyte ions from 
spectral interferences. Serum mineral concentrations were reported in milligrams per 
kilogram. 
 Serum IgG was measured using a radial immunodiffusion assay according to 
kit instructions (Bethyl Laboratories Inc., Montgomery, TX). Intraassay and interassay 
coefficients of variation for IgG were 3.2 and 3.6%, respectively. An SOD assay kit 
(Cayman Chemical Co., Ann Arbor, MI) was used, following the manufacturer’s 
instructions for assaying SOD activity in plasma. The intraassay coefficient of 
variation for SOD was 3.7%. Likewise, a Cayman GPx assay kit was used, following 
the manufacturer’s instructions to evaluate GPx activity. The intraassay coefficient of 
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variation for GPx was 7.2%. Serum Hp was evaluated following the method described 
by Makimura and Suzuki (1982). The intraassay coefficient of variation for Hp was 
9.8%. 
 Additionally, a random subset of 228 calves (112 control and 126 TMS-treated 
calves) from one of the farms was sampled to evaluate neutrophil and monocyte 
function at d 14 after birth. Neutrophil and monocyte function was measured by the 
neutrophil and monocyte phagocytic activity  using a PHAGOTEST  kit  (Orpegen 
Pharma GmbH, Heidelberg, Germany) containing fluorescein-labeled opsonized 
Escherichia coli (E. coli- FITC), following the manufacturer’s instructions. Cells were 
analyzed with a FACSCalibur flow cytometer (Becton, Dickinson and Co.) using a 
488-nm argon-ion laser. Ten thousands events were collected for each cell population 
(neutrophils or monocytes). The results are reported as the percentage of cells 
performing phagocytosis from the total number of cells in the granulocyte gate and as 
the increase mean of the green fluorescence of the gated cells. 
 
Case definitions 
The criterion to determine a case of pneumonia was the presence of two or 
more of the following clinical signs in a calf: cough, rectal temperature >39.5 °C, 
respiratory rate >40 breaths/minutes, increased cranioventral lung sounds or wheezes. 
Otitis was determined by observation of ear pain evidenced by head shaking and 
scratching at or rubbing ears, epiphora, ear droop, and signs of facial nerve paralysis, 
listlessness, and temperature >39.5 °C. The criteria do determine diarrhea was watery 
and fetid fecal consistency. Calves were recorded as diarrheic when diarrhea was 
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observed at least during 3 days throughout the study period.  
 
Statistical Analyses 
Descriptive statistics were performed using FREQ, MEANS, and 
UNIVARIATE procedures of SAS (SAS Institute). The initial body weight, IgG 
concentrations at day 3 after birth, percentage of calves born from primiparous cows, 
and assisted parturitions were evaluated to assure similar distribution between TMS 
and control calves within each farm and rearing systems. 
For all health events (pneumonia, otitis, diarrhea, otitis and/or pneumonia, and 
mortality) calves were right censored at the end of the study period (50 days of life). 
To evaluate the effect of treatment on pneumonia, otitis, diarrhea, otitis and/or 
pneumonia, and mortality five multivariable mixed logistic regression models were 
fitted to the data using the GLIMMIX procedure of SAS. The variable described as 
“otitis and/or pneumonia” characterize calves that were affected with otitis, 
pneumonia, or both. The variables treatment group, serum IgG concentration (3 days 
of life), and birth weight were offered to all models. Additionally, the variable farm 
was included in all models as a random effect. Adjusted probabilities of pneumonia, 
otitis, diarrhea, otitis and/or pneumonia, and mortality were obtained using the 
LSMEANS statement. 
The effect of treatment on ADG and leukocyte function was evaluated with 
general linear models using the MIXED procedure of SAS. Average daily gain was 
calculated subtracting the body weight at weaning (50 days of life) by the birth weight, 
and subsequently dividing by 50. Farm was used as a random effect and birth weight 
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and serum IgG concentration at 3 days of life were used as independent variables. 
Least square means and respective 95% confidence intervals were estimated for all 
categorical main effects. 
Mixed general linear models were fitted to the data using the MIXED 
procedure of SAS to analyze the effect of treatment, pneumonia, otitis, and mortality 
on the repeated measures (3, 14, and 35 days of life) of GPx, SOD, and Hp. To control 
for repeated measures, the animal identification number (nested within farm) was 
included in all models as a random effect and serum IgG concentration (3 days of life), 
and birth weight were included as covariates.  Separate models were used for 
treatment, pneumonia, otitis, and mortality to avoid multicollinearity. The interaction 
of each categorical variable and sampling time were offered to all models.  
For all general linear models, the assumption that the residuals were normally 
distributed was assessed by visually evaluating the distribution plot of the Studentized 
residuals. Statistical significance was declared when P-value was ≤ 0.05 and statistical 
tendencies were declare when 0.05 < P-value ≤ 0.10. 
 
RESULTS 
Descriptive statistics 
Average body weight (kg) at enrolment, serum IgG concentration at 3 days of 
life, percentage calves born to primiparous, percentage of assisted parturition, and 
number of calves enrolled in each calf farm by rearing system were not different for 
calves at TMS and control treatments (Table 2.2).
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Table 2.2: The percentage of calves born from primiparous cows, assisted parturition, initial body weight (kg), and calves` serum 
IgG concentrations at day 3 after birth (g/L) were evaluated between TMS and control calves within the farms rearing systems. The 
LSMEANS and the respective SEM are presented for initial body weight and serum IgG concentration. 
 
  Farm A 
(Group fed ad-libitum) 
Farm A 
(Individual fed restricted) 
Farm B 
(Individual fed restricted) 
  Control TMS P Control TMS P Control TMS P 
n 230 215  100 95  70 80  
Calves born to primiparous 37% 37% 0.9 27% 27% 0.9 43% 45% 0.8 
Assisted parturition 4% 5% 0.7 3% 5% 0.4 16% 18% 0.8 
Initial weight
 
42.2 (0.4) 41.9 (0.4) 0.4 40.4 (0.5) 41.1 (0.5) 0.4 41.3 (0.6) 41.1 (0.6) 0.8 
Serum IgG
 
23.5 (0.9) 24.0 (0.9) 0.7 22.4 (1.3) 23.2 (1.4) 0.7 26.7 (1.8) 25.7 (1.6) 0.7 
TMS, trace mineral supplemented calves administered at 3 and 30 days of age 
Initial weight, calves initial body weight (kg) at 3 days of life 
Serum IgG, calves serum IgG (g/L) measured at 3 days of life, before first treatment 
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Disease incidence and average daily gain 
 The effect of treatment on adjusted incidences of mortality, diarrhea, otitis, 
pneumonia, and otitis and/or pneumonia is presented on table 2. Briefly, TMS group 
calves had lower (41.7%) incidence of diarrhea when compared to control group 
calves (49.1%; Table 2.3). Average weight gain was not significantly different 
between treatment groups (P = 0.49). The ADG for calves enrolled into the TMS 
group was; 778 g/day (95% C.I.; 729 – 826) and 789 g/day (740 – 837) for calves in 
the control group. 
 
Table 2.3: A mixed logistic regression model was used to evaluate the effect of 
treatment on health events. Adjusted odds ratio and adjusted probabilities of 
pneumonia, otitis, diarrhea, otitis and/or pneumonia, and mortality were obtained 
using the LSMEANS statement. Adjusted odds ratios are presented with the respective 
95% confidence intervals.  
 
 Adjusted incidence % Adjusted odds ratio 
(95% C.I.) 
P-value 
 TMS
 
Control 
Mortality 3.8% 2.7% 0.70 (0.30 – 1.58) 0.39 
Diarrhea
 
41.7% 49.7% 1.38 (1.02 – 1.86) 0.03 
Otitis 10.6% 13.2% 1.26 (0.82 – 2.01) 0.30 
Pneumonia 35.2% 40.0% 1.23 (0.91 – 1.65) 0.18 
Otitis and/or pneumonia
 
41.6% 49.1% 1.35 (1.00 – 1.83) 0.04 
TMS, trace mineral supplemented calves administered at 3 and 30 days of age 
Diarrhea, calves affected with diarrhea for at least 3 days 
Otitis and/or pneumonia, this health event is characterized by calves that were affected 
with otitis, pneumonia, or both 
 
 
Blood leukocyte function 
 Peripheral blood leukocyte function was greater for TMS calves than for 
control calves at 14 days after birth (Figure 2.1). Briefly, TMS calves had increased 
neutrophils activity showing an increased mean fluorescence, i.e. number of ingested 
bacteria by neutrophils (P = 0.05) and percentage of neutrophils that performed 
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phagocytosis (P < 0.01) when compared with control calves.  
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Figure 2.1: Effect of trace mineral injections (TMS; 3 and 30 days of life) on the 
percentage and mean fluorescence intensity (reflecting ingested bacteria) of 
neutrophils and monocytes assessed on blood samples collected at 14 days. The dark-
gray bars represent calves on the control group and light-gray bars calves on TMS 
group. Trace mineral supplemented calves had greater overall neutrophil mean when 
compared to control calves. Error bar represent the standard error of the mean. * 
indicates P – value between 0.1 and 0.05, ** indicates P – value less than 0.05.  
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 Additionally, blood leukocyte function was not different for calves that were 
recorded with pneumonia, otitis, diarrhea, and calves that died before the end of the 
study period when compared with healthy and calves that survival during the study 
period (Figure 2.2). 
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Figure 2.2: Percentage and mean fluorescence intensity (reflecting ingested bacteria) 
of neutrophils and monocytes assessed on blood samples collected at 14 days of life. 
The dark-gray bars represent calves that were affected with otitis, pneumonia, 
diarrhea, and calves that died and light-gray bars represent calves that were not 
affected with disease and survival until the end of the study (50 days). Error bar 
represent the standard error of the mean. * indicates P – value between 0.1 and 0.05, 
** indicates P – value less than 0.05. 
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Oxidative stress and acute phase protein markers  
 Calves supplemented with trace minerals had increased GPx when compared 
with control calves at day 14 after birth. Interestingly, calves diagnosed with 
pneumonia had a significantly lower glutathione peroxidase activity at day 35 after 
birth when compared with healthy calves (Figure 2.3). There were no effects of 
treatment on serum SOD activity and Hp optic density at days 3, 14, and 35 after birth 
(Figure 4 and 5). Moreover, there were no effects of disease on calves` serum SOD 
activity and haptoglobin optic density (Figure 2.4 and 2.5).  
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Figure 2.3: Plasma glutathione peroxidase (GPx) activity (nmol/min/mL) was 
assessed on days 3, 14, and 35 of the calves` life. The light-gray lines represent the 
effect of trace mineral supplemented calves (TMS vs. control calves), pneumonia, 
otitis, and calves that survival until the end of the study period (50 days) on the 
repeated measurements of GPx. Error bar represents the standard error of the mean. * 
indicates P – value less than 0.05. 
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Figure 2.4: Serum superoxide dismutase (SOD) activity (U/mL) was assessed on days 
3, 14, and 35 of calves` life. The light-gray lines represent the effect of treatment, 
pneumonia, otitis, and calves that survival until the end of the study period (50 days) 
on the repeated measurements of SOD. No effect was observed on SOD activity for 
trace mineral treated calves (TMS vs. control calves), pneumonic calves (vs. healthy), 
calves diagnosed with otitis (vs. healthy), and calves that survival until the end of the 
study period (vs. calves that died). Error bar represents the standard error of the mean.  
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Figure 2.5: Serum haptoglobin (Hp) optic density (OD) was evaluated on days 3, 14, 
and 35 of calves` life. The light-gray lines represent the effect of treatment, 
pneumonia, otitis, and calves that survival until the end of the study period (50 days) 
on the repeated measurements of SOD. No effect was observed on Hp OD for trace 
mineral treated calves (vs. control calves), pneumonic calves (vs. healthy), calves 
diagnosed with otitis (vs. healthy), and calves that survival until the end of the study 
period (vs. calves that died). Error bar represents the standard error of the mean. 
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DISCUSSION 
As anticipated, supplementation with trace minerals at early postnatal life was 
beneficial to calves immunity and oxidative stress status. Calves supplemented with 
trace minerals had improved leukocyte function increasing its ability to perform 
phagocytosis and improved glutathione peroxidase activity. Trace minerals such as 
selenium, zinc and copper are required for functioning of enzymes involved in the 
antioxidant defense system and may also affect immune cells through mechanisms 
distinct from antioxidant properties. Selenium is an essential component of glutathione 
peroxidase enzymes destroying hydrogen peroxide and lipid hydroperoxides (Rotruck 
et al., 1973).  
Copper and zinc form the Cu–Zn superoxide dismutase (SOD), which is 
responsible for dismutation of superoxide radicals to hydrogen peroxide in the cytosol 
(Halliwell and Gutteridge, 1999). Zinc also induces synthesis of a metal binding 
protein that may scavenge hydroxide radicals called metallothionein (Prasad, 2004). In 
addition to an antioxidant role, zinc may affect immunity via its important role in cell 
replication and proliferation (Spears and Weiss, 2008). The increased activity of 
enzyme glutathione peroxidase suggests that the trace mineral supplementation can 
effectively reduce oxidative stress in calves in the first two weeks of life. Considering 
the particular immune cells sensitivity to oxidative stress, it is possible that improved 
phagocytosis ability of leukocytes was a function of the enhanced antioxidant status 
provided by the trace mineral supplemented.  
 Phagocytosis is one of the most important functions of the neutrophils playing 
a critical role on their ability to recognize and eliminate foreign and infected cells. The 
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effect of Se supplementation was already described to improve phagocytosis in white 
blood cells population (Hogan et al., 1990). Moreover, Suwanpanya et al. (2007) 
reported an increase in the neutrophils phagocytic activity on Staphylococcus aureus 
of heifers dietary supplemented with 3mg Se and 4,000 IU vitamin E per day. In the 
current study, 14 days old calves` peripheral blood neutrophils were tested against 
opsonized Escherichia coli and the results indicated significant improvement in the 
phagocytic activity for calves supplemented with 1mg of selenium at 3 days of life 
when compare with not supplemented calves.  Although trace mineral 
supplementation significantly increased glutathione peroxidase activity at 14 days of 
age in this study, no effect of treatment was observed at 35 days of life. Interestingly, 
the current study reported a decreased glutathione peroxidase activity for calves 
diagnosed with pneumonia and an increased activity for calves diagnosed with otitis. 
Cemek et. al (2006), report similar results in an investigation of antioxidant status in 
children with acute pneumonia where glutathione peroxidase activity was reduced in 
affected children compared to non-affected. Additionally, another study using human 
infants found a decreased level in plasma GPx in 57 patients with pneumonia when 
compared to 87 controls (Cui et al., 1997). 
Bonham et al., (2002) suggested that neutrophils function might be a valuable 
biomarker for copper status.  However, in the current study supplemental trace 
minerals did not influence superoxide dismutase, the antioxidant enzyme that uses 
copper and zinc to be synthesized. Likewise, haptoglobin a marker of acute phase 
protein was not affect by treatment. Acute phase proteins are well described as 
quantifiable indicators of inflammation of infection in adult cattle. However, there are 
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some factors that can significantly change acute phase protein concentration in 
neonatal calves; stress of birth, microbial challenge, and intake of colostral cytokines. 
The beneficial effects of trace mineral supplementation on immune function 
were ultimately reflected on lower incidence of diarrhea. Oral Zn supplementation was 
reported to reduce the incidence of diarrhea among children in developing countries 
(Funchs 1998; Hambridge et al., 2000). Furthermore, the effectiveness of zinc in 
children diarrhea was related to improvement in the enzymatic functions of the brush 
borders, and enhancement of the intestinal mucosa repair (Sazawal et al., 1995: Strand 
et al., 2002). 
However, the benefits of trace mineral supplementation herein reported did not 
translated in improved average daily gain. Clearly, within a calf rearing program a 
multitude of factors can play a role on growth and health status of calves. Factors such 
as individual measurements of DMI, milk consumption, and most important biological 
levels of trace minerals throughout the first 60 days of life may contribute to the 
results herein presented. Although, leukocyte function and oxidative stress status were 
improved in TMS calves the first two weeks of life, the absence of effects on average 
daily gain, pneumonia, otitis and survivability for TMS calves and the significant but 
punctual effect of TMS on neutrophils function should be carefully examined 
following the data used for these inferences. Future studies should consider individual 
DMI, milk consumption and biological levels of trace minerals in the pre-weaned 
period as potential factors to improve health and growth for dairy calves. 
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CONCLUSIONS 
  In conclusion, in this study trace minerals supplementation improved leukocyte 
function and oxidative stress status of dairy calves in first two weeks after birth. 
However, these benefits did not translate into improved growth performance and 
health status for dairy calves in the first 60 days of life. Some critical factors such as 
individual DMI, milk consumption, and biological levels of trace minerals may shed 
light on critical points for a proper supplementation of trace minerals that results in 
benefits for growth and performance. Therefore, the improved immunological status 
of dairy calves supplemented with trace minerals uncoupled with growth and health 
performance warrants further investigation. 
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ABSTRACT 
 The objective of this study was to evaluate the effect of standardized botanical 
extract of Croton lechleri named crofelemer extract, on fecal dry matter and fecal 
scores on diarrheic newborn Holstein bull calves induced by enterotoxigenic 
Escherichia coli (ETEC). A double-blinded randomized clinical trial was performed, 
60 newborn Holstein bull calves were clean caught and transported to an isolation 
facility where calves were individually housed and randomly assigned to one of three 
treatment groups; placebo (CTR), enteric-coated formulation of crofelemer extract 
(ECROF), and non-enteric coated formulation of crofelemer extract (CROF). Diarrhea 
was induced at first feeding with an inoculum of the ETEC (ATCC - 31616) 
administered with a third of the recommended dose of a colostrum replacer. All calves 
enrolled in this study received treatments starting on the second feeding (diarrhea 
onset) and treatments were administered before feeding time (600h and 1600h) for 6 
feedings consecutively. All calves in this study had failure of passive transfer. The 
only cause of death in this study was due to septicemia, accounting for one death out 
of each treatment group. All the calves were examined twice daily, within 2 hours 
after feeding, from day 1 (pre-challenge) until day 10, on day 15, and a last 
examination on day 25 of the calves` life. Five parameters were evaluated during each 
examination; rectal temperature, clinical assessment of dehydration status, fecal 
scores, attitude, and appetite. No differences were observed between treatment groups 
for rectal temperature, attitude, and appetite. Fecal dry matter was analyzed as pre-
challenge fecal dry matter, dry matter during treatment, and fecal dry matter after 
treatment cessation. No difference in pre-challenge fecal dry matter was observed and 
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pre-challenge fecal dry matter was used as a covariate in the models. Fecal dry matter 
during treatment was significantly higher for ECROF calves when compared to 
control calves and CROF calves. Additionally, ECROF fecal dry matter after 
treatment cessation had a statistical tendency to be higher when compared to control 
calves. Together, these results suggest that enteric coated formulation of the 
standardized crofelemer extract, a natural-product with anti-secretory properties, can 
significantly increase fecal dry matter of neonatal calves with experimentally induced 
enterotoxigenic Escherichia coli diarrhea. More research is needed to test the efficacy 
of enteric coated crofelemer on incidence and severity of secretory diarrhea on calves 
under natural challenge conditions.  
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INTRODUCTION 
 Considerable economic losses may be incurred from neonatal diseases during 
calf rearing. In 2010, diarrhea (18%) and pneumonia (16%) were the most common 
disorders affecting pre-weaned heifers reported by the National Animal Health 
Monitoring System (NAHMS, 2011). Diarrhea is a multifactorial disease that can be 
caused by infectious and non-infectious factors (Walker et al., 1998; O'Handley et al., 
1999). The risk factors known to be associated with diarrhea are; management 
(environmental condition), nutritional state, immune status, and pathogen exposure 
(Klein-Jöbstl et al., 2014; Al Mawly et al., 2015). Enteropathogens such as viruses, 
bacterial, and protozoa are often identified as etiological agents in calf diarrhea. The 
most common enteropathogens described in the literature include Escherichia coli, 
Salmonella spp., Cryptosporidium, and rotaviruses (Moon et al., 1978; O'Handley et 
al., 1999; Gulliksen et al., 2009; da Silva Medeiros et al., 2015). 
 Enterotoxigenic E.coli and neonatal diarrhea have been extensively studied in 
the last 4 decades (Bywater and Logan, 1974; Radostits, 1975; Acres, 1985). Much 
has been done to prevent early life contamination with enteropathogens; minimal dam-
calf contact, colostrum pasteurization, and disease control practices (Moon and Bunn, 
1993; Sandra, 2008; Naylor, 2009). In spite of efforts controlling neonatal diarrhea, it 
still remains as a major concern in the beef and dairy industry, with high impact on 
animal welfare and profitability (NAHMS, 2011; Hughes, 2013). 
 There are many important aspects on prevention and treatment of diarrhea due 
Escherichia coli. Vaccination of the cows before parturition can effectively provide 
antibodies against strains of enterotoxigenic Escherichia coli (ETEC) (Frantz et al., 
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1987). The vaccination can also prevent neonatal diarrhea (Nagy, 1980). Antibiotics 
have been used as treatment against diarrhea caused by Escherichia coli (Sunderland 
et al., 2003). However, the use of antibiotics is under scrutiny due to concerns of 
bacterial resistance that could impact human health. Alternative therapeutic treatments 
for diarrhea have become more common. Studies have been conducted testing the 
efficacy of organic and inorganic zinc, probiotics, and even bacteriophages targeting 
enteropathogens for treatment of diarrhea in calves (Muscato et al., 2002; Bicalho et 
al., 2012; Glover et al., 2013).  
 The FDA recently approved crofelemer, a polyphenolic molecule isolated from 
the latex of the plant species Croton lechleri of the family Euphorbiaceae indicated 
for idiopathic HIV-associated secretory diarrhea. Crofelemer has been studied for its 
antisecretory actions that involve the inhibition of two distinct chloride channels on 
the luminal membrane of the intestine; cystic fibrosis transmembrane conductance 
regulator (CFTR) and calcium-activated chloride channel (CaCC) (Tradtrantip et al., 
2010). Cystic fibrosis transmembrane conductance regulator is expressed at the apical 
membrane of enterocytes and plays an important role in the intestinal physiology. 
Enterotoxigenic Escherichia coli, secretes bacterial toxins that leads to the activation 
of CFTR and CaCC, consequently leading to chloride secretion and intestinal fluid 
hyper secretion (Thiagarajah and Verkman, 2013).  
 To the best of the authors’ knowledge, the efficacy of crofelemer extract as an 
antidiarrheal drug has not been previously evaluated in a neonatal bovine secretory 
diarrhea model. Here, we investigate the anti-secretory potential of crofelemer extract 
in newborn Holstein bull calves challenged with ETEC in the first day of life. The 
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objective of this study was to evaluate the effect of two formulations of crofelemer 
extract on diarrhea severity and consistency of experimentally-induced diarrhea in 
newborn Holstein calves in the first five days of life. As a second objective, the overall 
health status and performance of the calves were evaluated until 25 days of life. 
 
MATERIALS AND METHODS 
Experimental design 
 This experimental protocol was approved by the Institutional Animal Care and 
Use Committee (IACUC) of Cornell University (Protocol number 2013-0075). Sample 
size was based on a fecal dry matter measured on a pilot study. Using a mean 
difference between groups of 1.4, a treatment group standard deviation of 1.2 and a 
placebo group standard deviation of 1.7, with a treatment group ratio of 1, assuming a 
desired type I error rate of 5%, a power of 80%, a sample size of 18 calves per group 
was calculated. As 10% of mortality was anticipated, a total of 20 calves were enrolled 
in this study. 
 The study design was a double-blinded randomized clinical trial. 
Randomization was performed a priori to beginning of the trial using Excel random 
function to create a balanced number of calves per treatment group (n = 20 calves per 
group). Data collection blindness was simplified by treatment tablets similarities, 
tablets were manufactured to have same appearance (same color and size) and were 
inodorous. A total of 60 Holstein bull calves from one commercial dairy farm (King 
Ferry, New York) were enrolled in the study. Calves were clean caught at parturition 
(minimizing animal contact between dam/calf and calf/maternity bed) and within 2 
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hours transported to an isolation facility for research animals at Cornell University. All 
the calves were enrolled in the study within 3 hours after birth. Transportation and 
vehicle cleaning procedure were performed accordingly to the Animal Care and Use 
Procedure. Briefly, calves were transported using an adapted cargo-van; calves were 
kept inside individual crates with proper ventilation, and transported directly from the 
farm to the research facility. Cleaning and sanitization of the vehicle was performed 
30 minutes before and immediately after transportation.  
 Calves were individually housed in 16 square meter rooms with controlled 
temperature and humidity. Each isolation room had an individual inner-room, 
containing all the necessary instrumentation for feeding, treatments, weighing, 
cleaning, and data collection. No equipment was shared between calves. Additionally, 
calves were unable to have any contact with other calves and/or outside areas. 
Cleaning and sanitation of bottles, nipples, and buckets used to held milk (before and 
after each feeding), water (once daily), and calf starter (twice weekly) were manually 
performed by a three step cleaning procedure. The three step cleaning procedure 
consists in rinsing all the equipment with lukewarm water, scrubbing a mixture of hot 
water and alkaline detergent solution, and finally rinsing in chlorinated water. 
 Calves were fed antibiotic-free milk replacer (Nutrablend 22/20, Ranch-Way) 
by bottle on a 10% body weight daily basis twice a day (0600h and 1800h) during the 
first 3 days of life. Calves were gradually removed from bottles and encouraged to 
drink from the bucket. Water was available ad-libitum from day 1 until the end of the 
study. All calves were kept in the study until 25 days of life with ad-libitum access to 
calf starter (Calf starter 18% CP, DuMOR) starting on the 7
th
 day of life.  
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Escherichia coli inoculum and challenge 
 All the calves were challenged using an Enterotoxigenic Escherichia Coli 
(ETEC) serotype O9:K35:K99 (ATCC #31616). The ETEC inoculum used in this 
study was prepared two weeks previously to the beginning of the trial. Standard ETEC 
ATCC bacteria activation was performed using trypticase soy broth (Trypticase, 
Becton, Dickinson and Co.) to grow the bacteria for 8 hours and then on Luria-Bertani 
agar (Difco LB Agar, Becton, Dickinson and Co.)  for 18 hours at 37°C. The bacteria 
was suspended in phosphate-buffered saline with 10% dimethyl sulfoxide and stored 
in 10 ml aliquots at -70
o
C. The mean inoculum titer was 4 x 10
10
 colony-forming units 
per 10 ml.  
 All the calves were challenged at the research facility within 6 hours of life. A 
mixture of freshly prepared 1L of colostrum replacer containing 157g of colostrum 
replacer powder, approximately 35g of IgG (Calf Colostrum Replacer, Land O Lakes) 
was mixed with 10 ml of thawed ETEC inoculum. The mixture was administered 
within 1 minute after preparation for each calf via esophageal feeder. Feeder were 
used only once per calf and properly discarded (Oral Calf Feeder, Jorvet). 
 
Treatment administration and data collection 
 Calves were assigned into 1 of 3 treatment groups; control (CTR; n = 20), 
enteric coated formulation of crofelemer extract (ECROF; n = 20), and non-enteric 
coated formulation of crofelemer extract (CROF; n = 20). The treatments were 
administered before each meal for 3 days consecutively (total of 6 treatments per calf) 
starting on the first feeding after challenge.  
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 Only one trained caretaker was feeding the animals during the whole study 
period and only one member of the study group was responsible for the challenge, 
treatment administration and data collection. Calves were weighed at birth, 10, 15, and 
25 days of life using a portable scale. Blood samples were collected via jugular 
venipuncture using an 18-gauge by 3.8-cm needle in an 8-mL vacuum tube (Becton, 
Dickinson and Co.) without anticoagulant for serum. Blood samples were collected 
between the morning and afternoon feedings; the first blood sample (baseline) was 
taken immediately before challenge and 4 subsequent blood samples were taken daily.  
 Serum was harvested following centrifugation at 2,000 × g for 15 minutes at 
4°C. Serum IgG was measured using the second blood collection (2
nd
 day of life) 
using a radial immunodiffusion assay according to kit instructions (Bethyl 
Laboratories Inc.). Total solids (TS) were evaluated in serum samples using an optical 
refractometer.  
 All the calves were examined twice daily, within 2 hours after feeding, from 
day 1 (pre-challenge) until day 10, on day 15, and a last examination on day 25 of life. 
Five parameters were evaluated during each examination, rectal temperature, 
dehydration status, fecal scores, attitude, and appetite.  
 Dehydration status, attitude, and appetite scores were based on a numerical 
scale as follows; dehydration status: 0 = normal, eyes are bright and skin feels pliable; 
1 = mild dehydration, slight loss of skin elasticity, skin tent < 3 seconds, eyes not 
recessed into orbit; 2 = moderate dehydration, skin tent > 3 seconds but < 10 seconds, 
eyes slightly recessed into orbit; 3 = severe dehydration, skin tent > 10 seconds, eyes 
markedly recessed into orbit. Attitude: 0 = alert, 1 = depressed, 2 = non-responsive. 
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Appetite: 0 = normal, 1 = consuming less than half of the meal, 2 = consuming less 
than 25% of the meal, 3 = not consuming. Fecal scores were a 5 point scale score 
(Figure 3.1) based on fecal consistency.  
  
 
 
Figure 3.1: Fecal scores were based on diarrhea severity and the picture represents the 
5 point scale used to visually assess calf diarrhea on milk fed calves. From the left to 
the right; 0 = formed feces with normal color, 1 = pasty with normal color, 2 = liquid 
with normal color, 3 = watery with normal color, 4 = watery with abnormal color.  
 
 Fecal samples were also collected (20ml plastic vials) during each clinical 
evaluation via digital stimulation on the calf`s rectum to evaluate percentage of dry 
matter of the feces. Fecal dry matter was determined as described by Bellosa et al., 
(2011). Briefly, 5 to 20 g of the sample was weighed on a precision digital scale 
(6202-1S, Sartorius) and then dried at 108 
o
C for 24 hours using an oven (Model 10 
Lab Oven, Quincy Lab) and re-weighed immediately to determine the percent dry 
matter. 
 
Fluid therapy 
 As a rescue treatment, an oral electrolyte (Hydralyte, Lloyd Inc.) was  fed via 
bottle as an extra meal administered in between meal hours to calves that had a fecal 
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score ≥ 3 and dehydration score ≥ 2. Intravenous fluid therapy using isotonic sodium 
bicarbonate was administered by jugular vein catheter (70 mL/kg/hour) if calves were 
unable to stand, presenting very weak or no suckle reflex, and dehydration score ≥ 2. 
  
Statistical Analyses 
 A total of 24 examinations/samples were collected per calf in this study. For 
the continuous data collected on fecal dry matter (FDM) and rectal temperature, calf 
samples were used as pre-challenge (defined as the first examination/sample before 
the challenge), during treatment days (defined as the calf average data collected during 
3 days of treatments; 2nd to the 7th examination/sample), and after treatment cessation 
(defined as the calf average data collected after treatment cessation; 8th to the 24th 
examination/sample). Data on FDM and temperature was averaged within calf. 
 Statistical analyses were performed using JMP 10 (SAS Institute Inc.). An 
ANOVA was used to evaluate serum immunoglobulin (IgG). Blood samples from the 
second collection (post-challenge) were used to measure serum immunoglobulin-G. 
Intraassay and interassay coefficients of variation for IgG were 3.2 and 3.6%, 
respectively.  
 To evaluate the effect of treatment on the following dichotomized clinical 
outcomes; diarrhea (fecal score ≥ 3), depression (attitude score ≥ 1), hypophagia 
(appetite score ≥ 1), dehydration (dehydration score ≥ 2), and oral electrolyte 
administration (yes or no), Fisher`s exact test was used to compare the percentage of 
calves affected in each treatment group against control calves. Additionally, the 
number of events (diarrhea, depression, hypophagia, dehydration, and oral electrolyte 
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administration) recorded during treatments days and after treatment cessation, was 
evaluated using ANOVA comparing the treatment groups against the control group.  
 A mixed general linear (MGL) model was used to analyze the effect of 
treatment on rectal temperatures. Initial rectal temperature (pre-challenge) was used as 
a covariate in the MGL models to evaluate rectal temperature.  
 A mixed general linear (MGL) models were used to analyze the effect of 
treatment on average daily weight gain (ADG). Calves enrolled in the ECROF group 
had a numerically smaller average birth weight at enrollment when compare to calves 
on CTR and CROF groups (P = 0.14), for that reason, birth weight was used as a 
covariate in the MGL models to evaluate ADG. Average daily weight gain was 
calculated on days 10, 15 and 25 of the calves` life by subtracting the birth weight 
from the weight at 10, 15 and 25 days of life; this variables were then used as the 
outcome variable for the MGL models.  
 A similar mixed general linear (MGL) model was used to analyze the effect of 
treatment on serum total solids (TS). The data consists on TS measured at pre-
challenge (day 0), day 1, day 2, day 3, and day 4 of calves’ life. Pre-challenge TS 
measurement was used as covariate in this model. To control for repeated measures 
the animal identification number was added in the model as a random effect. 
For all general linear mixed models, the assumption that the residuals were 
normally distributed was assessed by visually evaluating the distribution plot of the 
Studentized residuals. Statistical significance was declared when P was ≤ 0.05 and 
statistical tendencies were declare when 0.05 < P ≤ 0.10. Results are presented as least 
square means and standard error of the mean.  
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RESULTS 
 Three calves, one in each group, were euthanized within 72 hours of life due to 
signs of bacteremia. Euthanasia (penetrating captive-bolt) was carried out by trained 
personnel. All data collected from these calves were not used in the analysis. Those 
calves were the only calves in the present study that needed intravenous fluid therapy 
(IV) and as a result, no IV data was used. All euthanized calves were submitted to the 
Animal Health Diagnostic Center (Cornell University) for a postmortem examination 
and sepsis was confirmed. 
 No statistical differences were observed for 24hr serum IgG (mg/ml) between 
treatment groups; 2.80 (±0.29), 3.00 (±0.28), and 2.85 (±0.27) for CTR, ECROF, and 
CROF groups respectively (P = 0.87). 
 Pre-challenged fecal dry matter (Figure 3.2) was not significantly different 
between treatment groups; 21.41% (±1.63), 20.67% (±1.55), and 21.25% (±1.64) for 
CTR, ECRO, and CROF respectively (P = 0.96). Average fecal dry matter was 
significantly higher for ECROF 15.45% (±1.55) calves during treatment days when 
compared to control calves 11.15% (±1.63) and when compared to CROF calves 
11.16% (±1.64). However, no difference was observed between CROF and control 
calves (P = 0.96). ECROF calves had a statistical tendency to have higher average 
fecal dry matter when compared to control calves (P = 0.08) following cessation of 
treatment. However, no significant difference in fecal dry matter after treatment 
cessation was observed between CROF and ECROF (P = 0.73) nor CROF and CTR 
(P = 0.16). 
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Figure 3.2: Effect of treatment on calves` fecal dry matter content (percentage of dry 
matter) measured on; pre-challenge, during treatment days, and after treatment 
cessation. Light gray bar represents control (CTR), dark gray bar represents enteric-
coated group (ECRO), and downward diagonal bar represents non-enteric coated 
group (CROF). Error bars are presented as standard error of the mean. Data are 
presented as means and standard error of the mean. Different letters within period 
(pre-challenge, during treatment days, and after treatment cessation) represent 
statistical differences (P < 0.05). 
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 Serum harvested from 5 blood samples per calf were used to measure total 
solids (TS, Figure 3.3) using an optical refractometer. There were no baseline (day 0) 
differences in TS between treatment groups (P = 0.54). There was a statistical 
tendency on day 1 collection in serum TS to be lower for calves in ECROF group 
when compared to CTR group (P = 0.06). No differences were found between 
treatment groups on day 2. Serum total solids were significantly higher for CTR calves 
when compared to ECROF calves (P = 0.03) and when compared to CROF calves (P 
= 0.05) on day 3, but no differences between ECROF and CROF groups. 
Additionally, serum total solids were significantly higher on day 4 collection for 
calves in CTR group when compared to ECROF (P = 0.05) and CROF (P = 0.02). 
 
 
 
Figure 3.3: Effect of treatment on calves` serum total solids measured on blood 
samples collected 5 times at; pre-challenge (day 0), day 1, day 2, day 3, and day 4 of 
calves’ life. Light gray bar represents control (CTR), dark gray bar represents enteric-
coated group (ECROF), and downward diagonal bar represents non-enteric coated 
group (CROF). Error bars are presented as standard error of the mean. Data are 
presented as means and standard error of the mean. Different letters within period 
represent statistical differences (P < 0.05). 
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 Diarrhea incidence pre-challenged was similar between treatment groups; 5.6% 
for CTR, ECROF, and CROF (P = 1). During treatment days, calves in the control 
group had 68.4% diarrhea incidence while calves in the CROF group had 84.2% (P = 
0.44) and calves in the ECROF group had 57.9% (P = 0.74). Additionally, no 
differences were found between the mean duration of diarrhea between control calves, 
calves in the CROF group, and calves in the ECROF groups. However, after treatment 
cessation control calves had 57.9% incidence of diarrhea while only 15.8% of the 
calves in the ECROF group were diarrheic (P = 0.007) and no differences were found 
between the control group and calves in the CROF group. Moreover, diarrhea duration 
was significantly lower for calves in the ECROF group when compared to calves in 
the control group (P = 0.02). 
 The percentage of calves with decreased appetite (hypophagia), and 
dehydration were not found to be significantly different between treatment groups at 
the pre-challenge, during treatment days, nor after treatment cessation between 
treatment groups (Table 3.1). 
 In addition to the clinical evaluation, rectal temperature was not significantly 
different between treatment groups before challenge; 38.9
o
C (±0.07), 38.8
o
C (±0.07), 
and 38.9
o
C (±0.07) for CTR, ECROF, and CROF respectively. No differences were 
found between treatment groups for calves` rectal temperature neither during 
treatment days (P = 0.90) nor after treatment (P = 0.94). 
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Table 3.1: Table regarding the effect of treatment on diarrhea, dehydration, calves` attitude (depression) and appetite (hypophagia), 
and oral electrolyte administration at pre-challenge, during treatment days (3 days consecutively), and after treatment cessation 
until 25 days of life. Pre-challenge data was collected once per calf, appetite and oral electrolyte administration measurements were 
not applicable. Control group was used as reference level for statistical comparisons. Data are presented as incidence (percentage of 
calves affected) and number of events (reported as mean and standard error of the mean). 
 
  
Pre-Challenge During Treatment After Treatment Cessation 
 
 Incidence P Incidence P 
Number 
of events 
P Incidence P 
Number 
of events 
P 
 
Diarrhea 
CROF
 
0 1 84 0.44 1.9 ± 0.4 0.61 42 0.52 1.0 ± 0.5 0.2 
ECROF
 
0 1 58 0.74 1.3 ± 0.4 0.11 16 0.01 0.3 ± 0.5 0.02 
CTR
 
0 Ref. 68 Ref. 2.2 ± 0.4 Ref. 58 Ref. 1.9 ± 0.5 Ref. 
Dehydration 
CROF 30 0.72 84 0.79 2.2 ± 0.4 0.77 47 0.74 1.0 ± 0.6 0.14 
ECROF 33 0.73 58 0.29 1.4 ± 0.4 0.21 42 0.75 1.0 ± 0.6 0.14 
CTR 37 Ref. 79 Ref. 2.0 ± 0.4 Ref. 53 Ref. 2.3 ± 0.6 Ref. 
Depressed 
CROF 37 0.85 84 0.01 1.5 ± 0.3 0.09 53 0.19 1.4 ± 0.5 0.88 
ECROF 35 0.84 37 1 0.6 ± 0.3 0.69 37 0.95 1.0 ± 0.5 0.76 
CTR 32 Ref. 37 Ref. 0.8 ± 0.3 Ref. 32 Ref. 1.3 ± 0.5 Ref. 
Hypophagia 
CROF NA 74 0.18 1.3 ± 0.3 0.73 42 0.51 1.2 ± 0.5 0.52 
ECROF NA 47 0.74 0.9 ± 0.3 0.57 37 0.33 1.2 ± 0.5 0.47 
CTR NA 53 Ref. 1.2 ± 0.3 Ref. 53 Ref. 1.7 ± 0.5 Ref. 
Oral 
Electrolytes 
CROF NA 95 0.71 3.4 ± 0.5 0.51 58 0.50 1.8 ± 0.6 0.31 
ECROF NA 74 0.70 1.9 ± 0.5 0.10 37 0.05 1.0 ± 0.6 0.06 
CTR NA 84 Ref. 2.9 ± 0.5 Ref. 68 Ref. 2.7 ± 0.6 Ref. 
CTR, Control group  
CROF, Non-enteric coated crofelemer group 
ECROF, Enteric-coated crofelemer group  
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 Calves birth weight (kg) was not significantly different between treatment 
groups; 42.7 (±1.13), 42.4 (±1.13), and 40.2 (±1.10) for CTR, ECROF, and CROF, 
respectively (P = 0.14). At 10 days of life a statistical tendency was observed, average 
daily gain was; 177.4g/day (±43.9), 285.4 (±41.7), and 223.5 (±43.9) for CTR, 
ECROF, and CROF groups (P = 0.08, Table 3.2). No statistical difference was 
observed between treatment groups at 15 days of life, average daily gain was; 233.9 
(±47.9), 292.9 (±42.9), and 254.0 (±46.5) for CTR, ECROF, and CROF groups (P = 
0.34). At 25 days of life, average daily gain was; 219.2 (±47.9), 281.2 (±44.1), and 
257.4 (±46.5) for CTR, ECROF, and CROF groups (P = 0.43). 
 
Table 3.2: Table regarding calves birth weight and the effect of treatment on average 
daily weight gain at 10, 15, and 25 days of life. Data are presented as means and 
standard error of the mean.  
 
 Treatment Groups P-value 
 CTR
 
ECROF
 
CROF
 
Birth weight, kg 42.7 (1.13)
 
42.4 (1.13) 40.2 (1.10) 0.14 
10 days ADG
 
177.4 (43.9) 285.4 (41.7) 223.5 (43.9) 0.08 
15 days ADG 233.9 (47.9) 292.9 (42.9) 254.0 (46.5) 0.34 
25 days ADG 219.2 (47.9) 281.2 (44.1) 257.4 (46.5) 0.43 
CTR, Control group 
ECROF, Enteric-coated Crofelemer group 
CROF, Non-enteric coated Crofelemer group 
ADG, Average daily weight gain calculated at each time point (g/day) 
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DISCUSSION 
 In the present study, two formulations of crofelemer extract were evaluated; an 
enteric-coated (ECROF) and a non-coated formulation (CROF). The ECROF 
formulation was significantly more effective in increasing fecal dry matter during 
treatment days when compared to CROF and placebo. Crofelemer has been studied for 
its antisecretory properties; crofelemer molecule can inhibit active chloride channels 
of enterocytes (Tradtrantip et al., 2010). Crofelemer targets the enterocyte 
extracellular surface and as such, an additional challenge is faced since the substance 
is susceptible to be washed away once in the lumen of the intestine due secreted fluid 
(Thiagarajah and Verkman, 2003). Tradtrantip et al., (2010) reported in vitro results 
indicating that crofelemer resisted washout, with less than 50% reversal of CFTR 
inhibition after 4 hours.  
 It is important to highlight that the effect reported by our study, favoring the 
enteric-coated form and not the non-enteric coated could be attributed to the enteric-
coating process during the tablet formulation. Constable et al. (2005) reported that 
average abomasal pH was 3.22 during a 24 hours interval on calves fed all milk-
protein milk replacer twice daily, and that the minimum preprandial pH was 1.34 and 
maximum postprandial pH was 6.07. The protection from the acidity of the abomasum 
by the enteric-coating process could have led to a higher concentration of the active 
component of the treatment into the intestinal lumen. 
 Fecal scores were used to visually assess calves affected with diarrhea. No 
differences were observed between treatment groups for the period of treatment. 
However, after treatment cessation, calves in the enteric-coated group had lower 
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incidence and lower number of diarrhea events. This finding is consistent with the data 
regarding oral electrolyte. Calves in the enteric-coated group had a tendency to 
received lower oral fluid therapy during treatment days and after treatment cessation.  
 In the current study, secretory diarrhea was induced by ETEC, which can 
rapidly lead to a high state of dehydration and life threatening conditions for newborn 
animals. As described by Hartmann et al. (1984, 1995) calves with watery diarrhea 
can lose up to 21% of its body weight.  However, in the present study, no differences 
were found between treatment groups when evaluating dehydration during days of 
treatment. Nevertheless, diarrheic calves with suckling reflexes and moderate 
dehydration were given oral fluid therapy. It could be possible that the quick detection 
of dehydration and subsequent fluid therapy (oral electrolyte administration) prevented 
the induced secretory diarrhea from causing severe dehydration. 
 Serum total solids (TS) were used as a laboratory measurement of dehydration. 
In cases of secretory diarrhea, water moves from the circulatory system into the 
intestinal lumen, concentrating the solid components of blood, leading to a higher total 
solids concentration and higher reading by the optical refractometer. In the present 
study, control calves had a strong statistical tendency to have higher total solids 
readings during second day of treatment when compared to enteric-coated formulation 
of crofelemer extract treated calves. Moreover, after treatment cessation, control 
calves had higher serum total solids reading when compared to crofelemer treated 
calves. Laboratory evaluation of blood components can be used to measure 
dehydration status by the analyses of total solids, packed cell volume, creatinine, and 
urea. However, considerable variation on blood components could be observed when 
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supportive therapy is in place (Abutarbush and Petrie, 2007). Constable et al. (1998) 
reported that these parameters are not as good parameters to determine dehydration as 
degree of enophthalmos and total protein measurements.  
 All calves enrolled in this trial had failure of passive transfer. This was 
expected given the intentional reduced amount of colostrum replacer administered to 
the calves during the challenge. In our study, septicemia was expected in some calves 
due to the nature of the challenge; calves were given a high amount of bacteria with a 
low amount of colostrum. Neonatal calves are highly susceptible to septicemia 
because they are dependent on colostral immunoglobulins (Fecteau et al., 2009). 
However, we experienced a lower mortality rate, only one calf in each group was 
euthanized due septicemia. 
 Hyperthermia and hypothermia were not found to be significantly different 
between treatment groups in this trial at pre-challenge, during treatment days, and 
after treatment cessation (data not shown). Lower temperatures were found elsewhere 
to be significantly associated with hypovolemic shock in cases of severe dehydration 
(Sunderland et al., 2003; Nagy and Fekete, 2005).  
 Average daily gain was not significantly different between treatment groups. 
Calves on ECROF group had a statistical tendency to gain 108 grams per day more 
when compared to control group during the first 10 days of life. Newborn calves are 
more susceptible to fluid losses due to their higher total water content and higher 
extracellular fluid volume (Hartmann et al., 1984; Hartmann and Reder, 1995). It is 
possible that the effect observed on weight gain difference was due to water losses in 
the feces. A study conducted in the early 70s comparing non-diarrheic calves with 
 90 
calves affected with spontaneous diarrhea reported that 96% of the weight lost in a 
diarrheic calf is due to water loss, in which 71.4%, 16.1%, and 12.5% of water loss 
was due fecal, urinary, and insensible, respectively (Phillips et.al., 1971). However, 
due the lack of calf starter consumption data little can be concluded from the data 
presented for the average daily weight gain calculated for the entire study period. 
 
CONCLUSIONS 
  Newborn diarrhea was induced using ETEC. Diarrheic calves were treated 
with two forms of crofelemer extract (enteric and non-enteric coated) administered 
twice a day for 3 days consecutively and compared to control calves (placebo). Results 
herein presented demonstrated that enteric-coated crofelemer extract, a natural-product 
with anti-secretory properties can significantly increase fecal dry matter on diarrheic 
neonatal calves. More research is needed to test the efficacy of enteric coated 
crofelemer on incidence and severity of secretory diarrhea on diarrheic calves under 
natural challenge conditions.  
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ABSTRACT 
 The objectives of this study were to evaluate the prophylactic use of SB-300, a 
standardized botanical extract on reducing fecal water losses and diarrhea events in 
Holstein bull calves individually housed under restricted whole milk feeding regime 
(6L/day) from 1 to 25 days of life. Furthermore, fluid therapy administration due to 
dehydration, weight gain, and fecal microbiome was also evaluated. Bull calves used 
in this study were born from normal parturition, fed 4L of pasteurized colostrum by 
esophageal feeder, and moved to a research facility at Cornell University. A double-
blinded randomized clinical trial was designed to allocate a total of 40 newborn calves 
into one of two treatment groups: calves receiving twice daily a solution containing 
500mg of SB-300 added to the whole milk for the first 15 days of life (SB-300, n = 
20) or control group receiving sterile water added to the whole milk for the same 
period (CTR, n = 20). Treatment solutions had a total volume of 10mL per treatment. 
Data regarding fecal dry matter was collected to precisely measure water content in 
fecal samples and also to define diarrhea events; SB-300 group had significantly 
increased fecal dry matter during the study period. Additionally, significantly fewer 
diarrhea events were observed for calves in the SB-300 (16.9%) when compared to 
calves in the CTR group (46.5%). Dehydration status was evaluated and treated 
accordingly; calves with moderate dehydration were offered oral electrolyte and 
calves with severe dehydration were submitted to intravenous fluid therapy. Calves in 
SB-300 group had fewer intravenous fluid therapy administered during the study 
period (1.6%) when compared to CTR treatment group (3.1%). Overall fluid therapy 
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administered (oral electrolyte plus intravenous fluid) was significantly higher for CTR 
group (9.2%) when compared to SB-300 group (6.1%) during the study period. No 
differences in milk consumption, calf starter intake, weight gain were observed 
between treatment groups. A single time increase in Bifidobacterium was observed at 
20 days of life for SB-300 group, no differences in fecal microbiome profile were 
reported between treatment groups. These results suggest that 500 mg of SB-300 
added to the milk for 15 days can reduce incidence of diarrhea and reduce severe 
dehydration in milk fed calves.  
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INTRODUCTION 
 Neonatal calf diarrhea is a multifactorial disease that can be caused by 
infectious and non-infectious factors (Walker et al., 1998; O'Handley et al., 1999). In a 
report from the National Animal Health Monitoring System 2010, diarrhea was the 
most common disorder affecting pre-weaned heifers, with a nationwide incidence of 
almost 19% and the leading cause of death in pre-weaned heifers (NAHMS, 2011). 
Enteropathogens such as viruses, bacterial, and protozoa are often identified as 
etiological agents in calf diarrhea (Cho and Yoon, 2013).  
 Depending on the pathogen, calf diarrhea could have different 
pathophysiological mechanisms. These mechanisms have been well explained for 
Escherichia coli enterotoxin-mediated secretory diarrhea (Thiagarajah and Verkman, 
2013), enterocytes villous atrophy-mediated malabsorptive diarrhea caused by 
Cryptosporidium parvum (Heine et al., 1984) and coronavirus (Lewis and Phillips, 
1978), and enterocyte villus atrophy and chloride secretion-mediated malabsorptive 
and secretory diarrhea caused by rotavirus (Thiagarajah and Verkman, 2003). Briefly, 
the mechanism of which loose stools are produced could be divided in: secretory, 
malabsorptive, or both. 
 Extensive review on prevention and treatment of neonatal calf diarrhea is 
available (Constable, 2009). Fluid therapy is still the hallmark treatment for 
undifferentiated naturally occurring neonatal calf diarrhea. However, approximately 
55% of calf operations facilities in the US make use of medicated milk replacers in 
attempt to control neonatal calf diarrhea and about 54% treat their scouring calves 
with antibiotics (Walker et al., 2012). The U.S. Food and Drug Administration 
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recommend five antimicrobials that can be used in medicated milk replacer for the 
control of bacteria, however; a maximum effort should be made to avoid routine 
administration of antibiotics as antimicrobial resistance could be a consequence of 
antimicrobial use (van den Bogaard and Stobberingh, 2000). Therefore, alternatives to 
antimicrobial for control and prevention of neonatal calf diarrhea are needed. 
 Recently, natural products with anti-secretory properties, proanthocyanidin 
oligomers, which are polyphenolic molecules extracted from the bark latex of the plant 
species Croton lecheri, had proved efficacy in reducing water losses measured in the 
fecal samples of neonatal Holstein bull calves were experimentally challenged with 
enterotoxigenic E. coli (Teixeira et al., 2015). This botanical extract has been studied 
for its antisecretory actions that involve the inhibition of two distinct chloride channels 
on the luminal membrane of the intestine; cystic fibrosis transmembrane conductance 
regulator (CFTR) and calcium-activated chloride channel (CaCC) (Fisher et al., 2004; 
Tradtrantip et al., 2010).  
 Therefore, the objectives of this study were to evaluate the efficacy of daily 
doses of a standardized botanical extract with anti-secretory properties in Holstein 
calves with naturally occurring diarrhea by reducing intestinal water secretion, 
reducing dehydration and fluid therapy use, and reducing the incidence of diarrhea 
during the first 25 days of life. As a second objective, we investigated the effect of the 
anti-secretory extract on the intestinal microbiota.  
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MATERIALS AND METHODS 
Experimental design, animals, and facility 
 This experimental protocol was approved by the Institutional Animal Care and 
Use Committee (IACUC) of Cornell University (Protocol number 2013-0075). Sample 
size was calculated based on a fecal dry matter difference previously evaluated by a 
pilot study. Based on an expected mean difference of fecal dry matter between 
treatment groups of 1.4, a treatment group standard deviation of 1.2 and a control 
group standard deviation of 1.7, with a treatment group ratio of 1, assuming a type I 
error rate of 5%, a power of 80%, a sample size of 18 calves per group was calculated. 
As 10% of mortality was anticipated, a total of 20 calves per group were enrolled in 
this study. 
 The study design was a double-blinded randomized clinical trial. 
Randomization was performed a priori to beginning of the trial using Excel random 
function to create a balanced number of calves per treatment group (Microsoft). A 
total of 40 Holstein bull calves from one commercial dairy farm (Scipio Center, New 
York) were enrolled in the study. Newborn Holstein bull calves were monitored 
during parturition by on farm staff. Calves were eligible to be enrolled in the study if 
no assistance was required during parturition, no twins, and no birth defects detected 
by physical exam after parturition. To mimic farm conditions, 4 L of pasteurized 
(60
o
C for 60min; T-300 GoodNature Products Inc.) pooled colostrum with Brix 
reading averaging 22.8% (ranging from 20.6% to 24.8%) was administered by 
esophageal tube to all calves within 45 minutes of birth (Oral Calf Feeder Bag with 
Probe, Jorvet).  
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 All the calves were transported from the farm to the study site within 4 hours 
after birth. Briefly, calves were transported using an adapted vehicle for animal 
transportation; calves were kept inside individual crates with proper ventilation. 
Cleaning and sanitization of the vehicle was performed before and immediately after 
transportation. 
  The study site was a research barn with controlled temperature (20.6
o
C, 
ranging from 19.4
o
C to 21.8
o
C) and humidity (50%, ranging from 45% to 55%) 
containing 20 individual stalls (2.1 square meters each) isolated by concrete walls, 
where calves were unable to have any contact with other calves and/or outside areas. 
A three step cleaning procedure was used for water buckets, feed buckets, and bottles 
after each feeding; consisting of rinsing all the equipment with lukewarm water, 
scrubbing a mixture of hot water and alkaline detergent solution, and finally rinsing in 
chlorinated water. The research barn used to conduct this trial was used twice; since 
limited space was available (20 stalls). A first run was performed from January to 
March of 2016 and the second run from March to May of 2016. The two runs were 
performed using the same exact procedures for enrollment, data collection, cleaning, 
and laboratory procedures. 
 Calves were fed saleable whole milk purchased from the Cornell Teaching 
Dairy (Cornell University) twice daily (0600h and 1800h) from first feeding to the end 
of study period at 25 d of life. From day one, calves were gradually encouraged to 
drink from the bucket. Water was available ad-libitum from day 1 until the end of the 
study. All calves were offered calf starter starting of day 16 of life (Calf starter 18% 
CP, DuMOR).  
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Treatment Administration and Data Collection 
 Randomization was performed in blocks (by dam parity and birth weight) a 
priori using random function in Excel (Microsoft). Calves were randomly assigned 
into 1 of 2 treatment groups; control (CTR; n = 20) or standardized botanical extract 
(SB-300; n = 20).  
 Treatment consisted of 500mg of SB-300 diluted in 10mL sterile water 
(VetOne) using a conical twisted top sterile tube (Corning Falcon). Treatments were 
prepared by adding 10mL of sterile water and 500mg of SB-300 into the 15ml conical 
tube and placing them in a benchtop tube mixer at low speed for 1 hour before each 
feeding (TubeRevolver, SoCal Biomedical). Treatments were administered twice daily 
during feeding by adding the solution into the milk for the first 15 days of life. Control 
calves were administered 10mL of sterile water by adding the solution into the milk, 
twice daily, for the first 15 days of life. 
 To accomplish double-blindness, one member of the research team only 
performed randomization and calf stall assignment. Another member of the research 
worked full time and was responsible for morning and evening feedings and 
treatments; treatments were added to the milk by the time of feeding. A third member 
of the research team was responsible for collecting the data. 
 Calves were weighed at birth, 5, 10, 15, 20, and 25 days of life using a digital 
portable scale (Waypig-15, Vittetoe Inc.). Rectal fecal swabs for metagenomic data 
were also collected at birth, 5, 10, 15, 20, and 25 days of life using DNA-free sterile 
swabs (6” Sterile DNA-Free Cotton Swab, Puritan Medical Products Company LLC) , 
placed into a 1.5ml sterile conical flask, number identified, and placed in a -80
o
C 
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freezer within 10 min of sampling. Blood samples were collected via jugular 
venipuncture using an 18-gauge by 3.8cm needle into 10mL vacuum tubes (Becton, 
Dickinson and Co.). Blood sampling was performed at the second day of life. Serum 
was harvested following centrifugation at 2,000 × g for 15 minutes at 4°C. Serum IgG 
was measured using the second blood collection (2
nd
 day of life) using a radial 
immunodiffusion assay according to kit instructions (Bethyl Laboratories Inc.).  
 All the calves were examined twice daily, within 2 hours after feeding from 
day 1 until day 25 of life. The following parameters were evaluated during each 
examination: rectal temperature (Digital Rectal Thermometer), eyes recession into the 
orbit, skin tent, attitude (suckling reflexes, standing position, and resting position), 
milk consumption, and calf starter intake (from 15 to 25 days of life).  
 Additionally, fecal samples were collected via digital rectal stimulation, 
sample was collected twice daily within one hour after feeding onto aluminum 
weighing boats from day 1 to day 15, at day 20, and a last collection performed once 
at 25 days of life and immediately used for dry matter evaluation. For all fecal samples 
collected, determination of fecal dry matter was performed as described by Bellosa et 
al., (2011). Briefly, samples were weighed on a precision digital scale (6202-1S, 
Sartorius) and then dried at 108
o
C for 24 hours (Model 10 Lab Oven, Quincy Lab) and 
re-weighed immediately to determine the percent dry matter. 
 A fixed amount of saleable whole milk was offered for the entire study period 
(3 L/feeding; 6 L total per day); milk consumption was measured after each meal from 
day one to the last day of the study. Calf starter was only offered after treatment 
cessation (treatment ceased on day 15 after second feeding); 4 kg of calf starter was 
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offered and weighed again at 25 days of life, average calf starter intake was calculated 
from day 16 until day 25 by subtracting the calf starter offered final weight (day 25) 
by the initial weight (day 16) and dividing by the 9 days. 
 Dehydration was assessed twice daily and fluid therapy was administered 
accordingly. Briefly, calves with bright eyes and skin feels pliable of a slight loss of 
skin elasticity (< 3 seconds), and eyes not recessed into orbit (≤ 2 mm) were 
considered not dehydrated and no rescue was performed. Calves with skin tent > 3 
seconds but < 10 seconds, eyes slightly recessed into orbit (>2 mm but ≤ 4 mm) and 
with sucking reflexes were considered moderate dehydrated and given oral fluid 
therapy. Oral hydration was also performed with a commercial oral electrolyte 
(Hydralyte, Lloyd Inc.); oral electrolyte was fed via bottle as an extra meal 
administered at time of physical exam (2 hours after each feeding). Calves with severe 
dehydration (skin tent > 10 seconds), eyes markedly recessed into orbit (≥ 5 mm), with 
or without suckling reflexes were considered severely dehydrated and given 
intravenous rescue therapy. Intravenous fluid therapy using isotonic sodium 
bicarbonate was administered by jugular vein catheter (70 mL/kg/hour). 
 
Next Generation Sequencing Methodology 
 Isolation of DNA from fecal content was performed by adding the cotton head 
of each sample to 1.5 ml of nuclease-free water (Life Technologies), and vortexed for 
two minutes. The swab was then removed and the sample was centrifuged for 10 
minutes at 13,200 x g. The supernatant was discarded and the remaining pellet was 
used for total metagenomic DNA extraction using the E.Z.N.A Stool DNA Kit 
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(Omega Bio-Tek) following manufacturers guidelines. Concentration and purity of the 
DNA were evaluated by optical density using a spectrophotometer (NanoDrop 
Technologies) and approximately 350ng of DNA was used for PCR procedure.  
 The 16S rRNA gene was then amplified by PCR from individual metagenomic 
DNA samples from the fecal content using barcoded primers. For amplification of the 
V4 hypervariable region of the bacterial/archaeal 16S rRNA gene, primers 515F and 
806R were used according to previously described methods and optimized for the 
Illumina MiSeq platform (Caporaso et al., 2012). The earth microbiome project 
(hearthmicrobiome.org) was used to select 280 different 12 base pair barcodes for the 
16S rRNA PCR, as previously described (Caporaso et al., 2012). The 5'-barcoded 
amplicons were generated in triplicate using 300 ng of template DNA, a master mix 
(Lucigen), and 10 µM of each primer. The PCR conditions for the 16S rRNA gene 
included an initial denaturing step of 94°C for 3 minutes followed by 35 cycles of 
94°C for 45 seconds, 50°C for 1 minutes and 72°C for 90 seconds and a final 
elongation step of 72°C for 10 minutes. Replicate amplicons were pooled and purified 
with a QIAquick PCR Purification Kit (Qiagen) and visualized by electrophoresis 
through 1.2% (wt/vol) agarose gels stained with 0.5 mg/ml ethidium bromide before 
sequencing.  
 
Statistical Analyses 
 Descriptive statistical analysis was undertaken in SAS (SAS Institute Inc.). An 
ANOVA was used to evaluate differences in birth weight (kg) at enrollment, serum 
immunoglobulin (IgG, g/L) collected at 2 d of life, and baseline fecal dry matter (%). 
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Additionally, the intraassay and interassay coefficients of variation for serum IgG 
quantified by an ELISA kit were 3.0 and 3.8%, respectively. Only 2 calves in the SB-
300 group and 1 calf in the control group died. Data from these calves were excluded 
from all statistical analysis. (2 days into the study). Differences in mortality was 
evaluated by Fisher`s exact test using the FREQ procedure in SAS. Briefly, all three 
calves were presenting persistent fever (rectal temperature > 39.5
o
C) from first 
feeding, depression (lost appetite, recumbency). Calves were defined as septicemic 
and antibiotic therapy with a supportive dose of corticosteroids and intravenous fluid 
administration was used, upon unsuccessful recover, euthanasia was performed. 
To evaluate the effect of treatment on daily milk intake, daily calf starter 
intake, and daily weight gain, five general linear models were fitted to the data using 
the GLM procedure of SAS. The independent variables offered to the models were; 
treatment group (CTR and SB-300), serum Immunoglobulin-G at 2 days of life (g/L), 
body weight at enrollment (kg), baseline fecal dry matter (%). Treatment group was 
the only variable forced into the models and a backward stepwise variable selection 
was performed. The assumption that the residuals were normally distributed was 
assessed by visually evaluating the distribution plot of the Studentized residuals. 
To evaluate the effect of treatment on fluid therapy (oral electrolyte, 
intravenous fluid, and overall fluid therapy), three multivariable mixed logistic 
regression models were fitted to the data using the GLIMMIX procedure of SAS. The 
independent variables offered to the model were; treatment group (CTR and SB-300), 
serum Immunoglobulin-G (g/L), body weight at enrollment (kg), and baseline fecal 
dry matter (%). Odds ratio and adjusted probabilities of diarrhea were obtained using 
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the LSMEANS statement. 
 A mixed general linear mixed model was fitted to the data using the MIXED 
procedure of SAS to analyze the effect of treatment on fecal dry matter (%).The 
independent variables offered to the model were; treatment group (CTR and SB-300), 
serum Immunoglobulin-G (g/L), body weight at enrollment (kg), and baseline fecal 
dry matter (%). Fecal dry matter data were longitudinally collected and consisted of a 
total of 33 measurements per calf: twice daily from day 1 to 15, twice daily at day 20, 
and one sample collected at 25 days of life before the end of the study. Therefore, data 
points were correlated within each research subject. To account appropriately for 
within-calf correlation, the error term was modeled by imposing a first-order 
autoregressive covariance structure. For this model a backward stepwise variable 
selection was performed. Furthermore, to assess the effect of treatment on fecal dry 
matter collected during the study period, the interaction between treatment and days 
was forced into the model. Visual evaluation of the distribution plot of the Studentized 
residuals allowed us to assume that the residuals were normally distributed. 
 To avoid subjectivity from visually scoring calves with diarrhea based on fecal 
consistency, diarrhea was defined after data on fecal dry matter were collected. The 
event of diarrhea was given to a calf that presented at least one of the twice daily 
measurements of fecal dry matter ≤ 10.0%. Data regarding events of diarrhea was 
created for each day from 1 to 15, at 20, and at 25 days of life. To evaluate the effect 
of treatment on diarrhea (yes or no), a multivariable mixed logistic regression model 
was fitted to the data using the GLIMMIX procedure of SAS. The independent 
variables offered to the model were; treatment group (CTR and SB-300), serum 
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Immunoglobulin-G (g/L), body weight at enrollment (kg), and baseline fecal dry 
matter (%). Adjusted probability of diarrhea was obtained using the LSMEANS 
statement. 
 The effect of treatment on body weight collected at 1, 5, 10, 15, 20, and 25 
days of life was evaluated by a mixed general linear model using the MIXED 
procedure of SAS. To control for repeated measures of body weight, the animal 
identification number (nested within run) was included in all models as a random 
effect and the independent variables offered to the model were treatment group (CTR 
and SB-300), serum Immunoglobulin-G (g/L), body weight at enrollment (kg), and 
baseline fecal dry matter (%). For this model a backward stepwise variable selection 
was performed and to assess the effect of treatment on fecal dry matter collected 
during the study period, the interaction between treatment and days was forced into 
the model. The assumption that the residuals were normally distributed was assessed 
by visually assessing the Studentized residuals plot.  
 Abundance of the individual genera; Bifidobacterium, Lactobacillus, 
Faecalibacterium, and Escherichia were evaluated using 4 similar general linear mixed 
models in SAS. Variables offered to the models included treatment group (CTR and 
SB-300), days (1, 5, 10, 15, 20, and 25 days of life), and the interaction terms between 
these two variables. To account appropriately for within-calf correlation, the error 
term was modeled by imposing a first-order autoregressive covariance structure. 
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RESULTS 
 Forty newborn Holstein bull calves were enrolled in this study. No differences 
in mortality was observed, 2 calves in the SB-300 group and 1 calf in the CTR group 
(P = 0.38). Birth weight was also not different between CTR (37.6 kg, 95% 
Confidence Interval = 37.4 – 38.4) and SB-300 (37.7 kg, 95% CI = 37.4 – 38.4). 
Serum IgG quantification was performed at the second day of life and no differences 
were found between calves in the CTR group (12.3 g/L, 95% CI = 11.6 – 13.0) and 
SB-300 group (12.1 g/L, 95% CI = 11.4 – 12.8). Additionally, no differences were 
found for baseline fecal dry matter between treatment groups (P = 0.55, Table 4.1). 
 
Table 4.1: Newborn Holstein bull calves were fed pasteurized pooled colostrum, 
individually housed, fed restricted whole milk (6L/day) from day 1 to 25 days of life, 
and offered calf starter from day 16 to 25 of life. Descriptive table regarding number 
of calves enrolled in each group, percentage of calves that died during the study 
period, serum immunoglobulin G concentration (IgG, g/L), birth weight (kg), and 
baseline fecal dry matter (%) is presented. Results are presented as means and 
respective 95% confidence interval (95% CI). 
 
  
Control SB-300
 
P-value 
n 
 
20 
 
20 
  
Mortality, % 
 
5% 
 
10% 
 
0.38 
  Means (95% CI)  
Birth weight, kg 
 
37.6 (37.3 - 37.9) 37.7 (37.4 - 38.4) 0.57 
Serum IgG, g/L 
 
12.3 (11.6 - 13.0) 12.1 (11.4 - 12.8) 0.72 
Fecal dry matter baseline, % 
 
29.8 (23.5 - 36.1) 27.2 (20.9 - 33.5) 0.55 
SB-300, calves in the standardized botanical extract group 
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Milk Intake, Calf Starter Intake, and Average Daily Gain 
 No differences were observed for milk and calf starter intake between 
treatment groups (Table 4.2). Briefly, calves in the CTR group had an average milk 
intake of 5.38 L/d (95% CI = 5.11 – 5.65) and calves in the SB-300 group an intake of 
5.55 L/d (95% CI = 5.28 – 5.83). Calf starter was only offered after treatment 
cessation at 16 d of life. Calf starter intake was not significantly different between 
treatment groups (P = 0.69). Moreover, no differences on average daily weight gain 
was observed from 1 to 25 days of life; calves in the CTR group had an average daily 
weight gain of 0.38 kg/d (95% CI = 0.27 – 0.49) and calves in the SB-300 group had 
an average of 0.43 kg/d (95% CI = 0.30 – 0.55). 
 
Table 4.2: The effect of treatment on milk consumption from day 1 to 25 days of life, 
calf starter intake from day 16 to 25 days of life, and the effect of treatment on average 
daily gain (divided in 3 periods; 1 to 15 days, 15 to 25 days, and from 1 to 25 days of 
life) were evaluated by 5 different general linear mixed models. Results are presented 
as means and respective 95% confidence interval (95% CI). 
 
  
Control SB-300 
P-value 
n  19 18 
 Period Means (95% CI) 
 
Milk intake, L/day 1 to 25 5.38 (5.11 – 5.65) 5.55 (5.28 – 5.83) 0.29 
Calf starter intake, kg/day 15 to 25  0.16 (0.15 – 0.17) 0.16 (0.15 – 0.17) 0.69 
 
1 to 15 0.14 (0.12 – 0.18) 0.17 (0.14 – 0.21) 0.22 
Weight gain, kg/day 15 to 25  0.74 (0.56 – 0.92) 0.89 (0.71 – 1.08) 0.22 
 
1 to 25 0.38 (0.29 – 0.47) 0.46 (0.37 – 0.56) 0.22 
SB-300, calves in the standardized botanical extract group  
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Dehydration and Fluid Therapy 
 During the study period, no differences were observed between treatment 
groups when evaluating the odds of a calf being moderately dehydrated and needing 
oral electrolytes (OR = 0.07, P = 0.09, Table 4.3). The odds of a calf being severely 
dehydrated and consequently needing intravenous fluids was 0.5 lower for calves in 
the SB-300 group when compared to calves in the CTR group (P = 0.04). Likewise, 
the odds of needing any fluid therapy (due moderate and severe dehydration) during 
the study period were 0.6 times lower in the SB-300 group when compared to the CTR 
group. 
 
Table 4.3: Dehydration was assessed twice daily for all calves in the study from day 1 
to 25 days of life; calves with moderate dehydration were offered oral electrolyte and 
calves with severe dehydration were rescued with intravenous fluid therapy. The effect 
of treatment on fluid therapy was evaluated by 3 generalized linear mixed models. 
Calves in the control group were used as a reference level. Adjusted probabilities, 
odds ratio and the respective 95% confidence interval (95% CI) are displayed.  
 
 
Adjusted Probability 
OR (95%CI) P-value 
 
Control SB-300
 
Oral Electrolytes 6.3% 4.5% 0.7 (0.5 - 1.0) 0.09 
Intravenous Fluids 3.1% 1.6% 0.5 (0.3 - 0.9) 0.04 
Overall Fluid Therapy 9.2% 6.1% 0.6 (0.4 - 0.9) 0.01 
SB-300, calves in the standardized botanical extract group 
 
Fecal Dry Matter and Diarrhea 
 A significantly higher fecal dry matter percentage was observed for calves in 
the SB-300 group (18.2 %, 95% CI = 17.2 – 19.2) when compared to calves in the 
CTR group (13.2 %, 95% CI = 12.2 – 14.2) during the study period (P <.0001, Figure 
3.1). Likewise, when evaluating the effect of treatment on events of diarrhea, calves in 
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the SB-300 group had significantly fewer events of diarrhea (16.9 %, 95% CI = 12.4 – 
22.5) when compared to calves in the CTR group (46.5 %, 95% CI = 39.9 – 53.2) 
during the study period (P <.0001, Figure 4.2). For both outcomes, the interaction 
term between treatment group and days of life was not significant and was forced in 
the models to generate daily estimates for both, fecal dry matter (P = 0.22) and 
diarrhea (P = 0.75). 
 
 
 
Figure 4.1: Fecal dry matter was performed twice daily for each of the treatment day 
(day 1 to 15). Additional samples were collected twice at day 20 and once at day 25 
before the end of the study. Treatments were administered twice daily with whole milk 
for the first 15 days of life. The effect of treatment, days, and the interaction between 
treatment and days are also displayed. Solid line represents calves in the control group 
(CTR, n = 19) and dashed line represents calves in the standardized botanical extract 
group (SB-300, n = 18). Y axis represents fecal dry matter least square means and X 
axis represents days into the study. Errors bars are displaying standard errors.   
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Figure 4.2: Diarrhea was recorded every day for all the calves in the study; an event 
of diarrhea was confirmed when a calf fecal sample presented at least one of the twice 
daily measurements of fecal dry matter equal or less than 10.0%. Treatments were 
administered twice daily with whole milk for the first 15 days of life. The effect of 
treatment, days, and the interaction between treatment and days are also displayed. 
Solid line represents calves in the control group (CTR, n = 19) and dashed line 
represents calves in the standardized botanical extract group (SB-300, n = 18). Y axis 
represents the model adjusted proportion of calves with diarrhea and X axis represents 
days into the study. Errors bars are displaying standard errors. 
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Body Weight 
 No effect of treatment was observed for body weight data collected during the 
study period (P = 0.42, Figure 4.3). The interaction term between treatment group and 
days of life was not significant and was forced into the model (P = 0.14). Briefly, 
body weight by the end of the study period (25 d of life) was 49.2 kg (95% CI = 47.7 – 
50.6) for calves in the SB-300 group and 47.0 (95% CI = 45.6 – 48.5) for calves in the 
CTR group. 
 
 
 
Figure 4.3: The effect of treatment on body weight collected at 5, 10, 15, 20 and 25 
days of life was evaluated by a general linear mixed model. The effect of treatment, 
days, and the interaction between treatment and days are displayed. Y axis represents 
the least square means of body weight and the X axis represents the days of body 
weight measurement. Dark gray bars represent calves in the control group (CTR, n = 
19) and light gray bars represent calves in the standardized botanical extract group 
(SB-300, n = 18). Standard errors are displayed as error bars. 
  
20
25
30
35
40
45
50
55
1 day 5 days 10 days 15 days 20 days 25 days
Treatment (p-value = 0.42)
Days (p-value <.0001)
Treatment*Days (p-value = 0.14)
B
o
d
y
 W
ei
g
h
t 
(k
g
) 
CTR SB-300
 114 
Fecal Microbiome 
 The three most abundant phyla described in this study were Firmicutes, 
Proteobacteria, and Bacteroidetes regardless of the treatment group. No differences in 
mean relative abundance of each phylum within days of life between treatment groups 
were observed (Figure 4.4). To investigate beneficial genera of intestinal bacteria, an 
individual evaluation of the following bacterial genera was performed; 
Bifidobacterium (Vlkova et al., 2006; Bunesova et al., 2012), Lactobacillus 
(Ewaschuk et al., 2004), and Faecalibacterium (Oikonomou et al., 2013; Foditsch et 
al., 2015). Additionally, the Escherichia genus was also considered for its known 
association with unhealthy microbiome (Acres, 1985). Bifidobacterium had a higher 
mean relative abundance at 20 d of life for SB-300 calves when compared to CTR 
calves (P < 0.05). However, that was the only difference observed from data regarding 
genera; no differences were found between any of the mean relative abundance of 
genera within days between treatment groups (Figure 4.5).  
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Figure 4.4: Descriptive distribution of the mean relative abundance of the most 
prevalent bacterial phyla identified in fecal samples of control calves (CTR, n = 19) 
and calves receiving standardized botanical extract (SB-300, n = 18). Fecal samples 
were collected once daily at 1, 5, 10, 15, 20, and 25 days of life.  
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Figure 4.5: Comparison of mean relative abundance of three genera previously 
associated with healthy gut microbiome represented by Bifidobacterium (A), 
Lactobacillus (B), Faecalibacterium (C), and one genus related to unhealthy 
microbiota represented by Escherichia (D) found in fecal samples. Y axis represents 
the mean relative abundance in percentage and the X axis represents the data point of 
each fecal sample collected (days of sampling). Dark gray bars represent calves in the 
control group (CTR, n = 19) and light gray bars represent calves in the standardized 
botanical extract group (SB-300, n = 18). Standard errors are displayed as error bars. 
Statistical significance adjusted by Bonferroni within each day is presented as * (P < 
0.003). 
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DISCUSSION 
 This double-blinded randomized clinical trial evaluated the prophylactic use of 
a standardized botanical extract administered twice daily at feeding mixed with 
saleable whole milk for the first 15 days of life on naturally occurring diarrhea. 
Diarrhea was precisely defined by measuring dry matter content in fecal samples 
collected twice daily from day 1 to 15, at 20, and at 25 days of life. Decreased 
incidence of undifferentiated naturally occurring diarrhea (defined as fecal dry matter 
≤ 10.0%) and fewer administration of fluid therapy (due to severe and moderate 
dehydration) in Holstein bull calves housed individually and fed restricted amount of 
saleable whole milk for 25 days were the main findings of this study. No differences 
were found in milk consumption, average daily weight gain. No effect of treatment on 
the intestinal microbiome was observed besides a transitory increase for the genera 
Bifidobacterium at 20 days of life for calves in the SB-300 groups when compared to 
control group calves. 
 Four main enteropathogens are associated with neonatal calf diarrhea; 
enterotoxigenic Escherichia coli as the main secretory-induced diarrhea pathogen, 
Cryptosporidium parvum and coronavirus are the main villus atrophy malabsorptive-
induced, and rotavirus capable of causing diarrhea by both pathways (Reynolds et al., 
1986; Varshney et al., 1995; Gulliksen et al., 2009b; Cho and Yoon, 2013). These 
pathogens can induce secretory diarrhea by increasing chloride secretion in the 
intestinal lumen, consequently leading to intestinal fluid hyper secretion (Thiagarajah 
and Verkman, 2003). Polyphenolic molecules isolated from the bark latex of Croton 
lechleri of the family Euphorbiaceae, have being extensively studied for its anti-
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secretory properties (Fisher et al., 2004). These standardized botanical extracts are 
inhibitors of two distinct chloride channels which are responsible for intestinal 
chloride secretion; cystic fibrosis transmembrane conductance regulator (CFTR) and 
calcium-activated chloride channel (CaCC) (Thiagarajah et al., 2004). Previously, the 
antisecretory properties of the standardized botanical extract in a single agent 
challenged secretory-induced diarrhea set-up, was proven to significantly decrease 
water content in fecal samples (Teixeira et al., 2015).  
 The antisecretory properties of the SB-300 are very specific therefore, the 
differences found in fecal dry matter percentage and consequently events of diarrhea 
can only be due its effect of blocking enterocytes chloride channels avoiding water 
sequestration into the intestinal lumen. In the current study, a twice daily dose of 500 
mg per feeding (3L whole saleable milk) of SB-300 for the first 15 days of life was 
able to reduce water secretion in fecal samples and consequently reduce the incidence 
of diarrhea. Mixed infection are often reported in calves suffering from naturally 
occurring diarrhea (Reynolds et al., 1986). The diarrhea affecting calves in this trial 
can be considered undifferentiated naturally occurring diarrhea, since no attempt to 
identify the cause of diarrhea was made. The prevalence of pathogens capable of 
producing secretory-induced neonatal diarrhea was elsewhere described to range 
between 2.0% to 45.0% and 17.0% to 80.0% for enterotoxigenic Escherichia coli and 
rotavirus, respectively (Reynolds et al., 1986; Frank and Kaneene, 1993; Luginbuhl et 
al., 2005; Gulliksen et al., 2009a; Bartels et al., 2010; Smith, 2012; Cho et al., 2013; 
Klein-Jöbstl et al., 2014).   
 Assessing dehydration and accurately identifying a calf that requires fluid 
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therapy is very important. During an event of secretory diarrhea, a calf can lose 
significant amount of body fluids and with it blood electrolytes (Dalton et al., 1965; 
Phillips et al., 1971; Fisher and De la Fuente, 1972). Dehydration can be successfully 
treated and provide calves with the necessary electrolytes and nutrients to restore its 
hydration status (Lewis and Phillips, 1978; Groutides and Michell, 1990; Hartmann 
and Reder, 1995; Sen et al., 2009; Smith, 2009). As previously described in calves 
with induced dehydration and diarrhea, the best clinical predictor of dehydration in 
neonatal calves are the degree of enophthalmos and neck skin-tent duration (Constable 
et al., 1998).  
 In the current trial, degree of dehydration was assessed by both described 
methods and fluid therapy was performed accordingly. Oral electrolyte administration 
was provided when a calf was found with moderate dehydration; no differences were 
found between treatment groups. However, a significantly higher number of 
intravenous fluids due to severe dehydration were administered for calves in the 
control group when compared to calves in the SB-300 group. Finally, overall fluid 
therapy administration (oral and intravenous fluids) was significantly different 
between treatment groups. In this study, calves suffering from undifferentiated 
diarrhea could have benefited from the constant dose of the standardized botanic 
extract offered twice daily for 15 days; as reported by Phillips et al, (1971) neonatal 
calves suffering from secretory diarrhea can lose up to 71.4% of water in its feces and 
reducing this intestinal water secretion can reduce the severity of dehydration. 
  In this present study, calves were offered a restricted amount of milk per day 
(6L) from day 1 to 25 days of life and calf starter was only offered after treatment 
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starting at day 16 until 25 d of life. Milk was offered even if a calf was under fluid 
therapy, as reported by others, calves suffering from diarrhea would benefit from the 
energy provided by the milk offered during feeding (Heath et al., 1989; Garthwaite et 
al., 1994). No differences were found between daily milk consumption and starter 
intake, in addition to no effects on average weight gain. The standardized botanical 
extract is a non-absorptive compound that exerts its inhibition function from the 
extracellular side of the enterocytes, having no effect on the enterocyte function as 
nutrient absorption (Holodniy et. al., 1999). In a multi-herd study evaluating risk 
factors that could impair calf growth, neonatal calf diarrhea was one of the risk factors 
associated with lower body weight gain (Virtala et al., 1996; Windeyer et al., 2014). In 
the current study, besides the higher incidence of diarrhea observed for calves in the 
control group, body weight was not significantly different between treatment groups 
during the study period.  
 Here, we investigate the effect of a botanical extract on the fecal microbiota 
using a metagenomic approach. In this study, the hypothesis behind the microbiome 
investigation was that; a lower secretion of water during an event of secretory diarrhea 
would lead to a more stable microbiome, possibly favoring beneficial bacteria that 
could lead to an improved performance. During events of diarrhea triggered by E. coli, 
rotavirus, and coronavirus the intestinal lumen can create a favorable environment for 
pathogenic bacteria overgrowth (Tzipori et al., 1981; Tzipori et al., 1983; Kaske, 
1993). The neonatal calf intestinal microbiota is dynamic during the first week of life 
and different intestinal microbiota profiles can be associated with disease and weight 
gain (Uyeno et al., 2010; Oikonomou et al., 2013; Malmuthuge et al., 2015). In 
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neonatal calves, the beneficial effects of decreasing diarrhea incidence and improving 
weight gain in calves have been reported when a higher prevalence of certain bacterial 
genera are provided, namely Lactobacillus, Bifidobacterium, and Faecalibacterium 
(Abe et al., 1995; Foditsch et al., 2015). In the current study, fecal swabs were 
collected during treatment days for metagenomic sequencing and no differences in 
relative abundance between treatment groups were detected for genera Lactobacillus, 
Bifidobacterium, and Faecalibacterium. Fecal swabs were also collected at day 20 and 
at day 25 of life; a difference was observed at day 20 only for Bifidobacterium 
between treatment groups, where calves in the SB-300 group had a higher relative 
abundance of Bifidobacterium when compared to calves in the control group. 
However, by day 25 no differences were reported. 
   
CONCLUSIONS 
   Forty newborn Holstein bull calves fed pasteurized pooled colostrum were 
raised under restricted feeding of saleable whole milk, housed individually from day 1 
to 25 days of life. A prophylactic dose of 500mg of SB-300 was added to the milk 
twice daily at feeding times for 15 days and diarrhea events were precisely identified 
by percentage of water in the feces. Calves in the SB-300 treatment group experienced 
significantly fewer events of diarrhea during the study period (16.9%) when compared 
to CTR calves (46.5%). Calves in the CTR group suffered more from severe 
dehydration and had higher intravenous fluid therapy intervention. No effect of 
treatment on average milk intake, calf starter intake, and average daily weight gain 
was observed. Besides a single time increase in Bifidobacterium observed at day 20 
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for SB-300 group, no differences in fecal microbiome profile was reported between 
treatment groups. Combined, these results suggest that 500 mg of SB-300 added to the 
milk during feeding for 15 days can reduce incidence of diarrhea and reduce severe 
dehydration in milk fed calves. 
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ABSTRACT 
 The objective of this study was to evaluate the efficacy of two metaphylaxis 
approaches (long acting antibiotic injected once at 10 days of life or twice at 10 and 35 
days of life) on the prevention of bovine respiratory disease (BRD), otitis, and 
mortality in high-risk group-housed pre-weaned Holstein heifer calves. The antibiotic 
of choice for the metaphylactic approach was a long acting macrolide (tildipirosin) 
administered subcutaneous on the base of the neck at a dose of 1ml for 45 kg of body 
weight. A clinical trial was carried out on one dairy farm with random allocation of 
newborn calves to one of 3 treatments: 1) control (CRT), 2) one injection at 10 days of 
life (M1), and 3) two injections at 10 and 35 days of life (M2). Study heifers (n = 795) 
were reared in group pens of 25 calves per pen and fed unrestricted acidified non-
saleable milk from day 1 until 65 days of life. Cox proportional hazard and general 
linear mixed models were used to evaluate the effect of treatment on mortality, BRD 
and otitis, and average daily weight gain.  
 Proportion of calves with inadequate transfer of passive immunity, birth 
weight, proportion of calves born from primiparous dams, and proportion of calves 
born from assisted parturitions were not different between CTR, M1, and M2 
treatments, respectively. A statistical tendency to have lower hazard of BRD was 
observed for M1 (HR = 0.68, P = 0.07) when compared to CTR group. Calves in M2 
group also had a tendency for a lower hazard of BRD when compared to CTR group 
(HR = 0.70, P = 0.09).  
 Additionally, a significantly lower hazard of having the combined BRD and 
otitis events was observed for M1 (HR = 0.70, P = 0.009) and M2 (HR = 0.72, P = 
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0.01). Metaphylactic treatments had no effect on mortality, otitis, and average daily 
weight gain during the pre-weaning period.  
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INTRODUCTION 
 The National Animal Health Monitoring Survey (NAHMS) reported that 
bovine respiratory disease (BRD) accounts for 22.5% of all pre-weaned dairy heifer 
mortality in the United States (USDA, 2007). Bovine respiratory disease is a 
multifactorial process which is typically initiated by an environment stressor or a viral 
infection that weakens pulmonary defense mechanisms, often allowing bacterial 
colonization (Yates, 1982; Griffin et al., 2010). Microorganism such as Mannheimia 
haemolytica, Pasteurella multocida, Histophilus somni, and Mycoplasma spp. are 
consistently regarded as the primary bacterial causes of BRD (Autio et al., 2007; 
Angen et al., 2009).  
 Historically, heifer calves have been raised from birth to weaning in individual 
hutches, to minimize direct contact and disease transmission, and fed a liquid diet of 
whole milk, non-saleable milk, or milk replacer twice daily at 10% of body weight 
(Drackley, 2008). This traditional system is the most common heifer-raising practice 
in the United States; approximately 75% of heifer-raising operations, despite the 
growing concern on animal welfare and labor costs associated with this practice (Kung 
Jr. et al., 1997; Chua et al., 2002; NAHMS, 2011). Additionally, the restricted amount 
of milk fed throughout the pre-weaning period can lead to reduced heifer growth and 
impact future productivity when compare to unrestricted or intensified feeding 
systems (Appleby et al., 2001; Soberon et al., 2012).  
 Group-housed heifer-raising operations typically group 10 to 25 calves in a 
single pen and provide unrestricted access to a liquid diet (whole milk, non-saleable 
milk, or milk replacer). To support unrestricted feeding, a common practice is to 
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conserve non-saleable milk or milk replacer by acidification (Nocek and Braund, 
1986, Richard et al., 1988). This alternative system provides advantages to both the 
dairy producer and the calves, allowing a more natural behavior, improving weight 
gain and reducing labor requirements (Kung Jr. et al., 1997; O’Driscoll et al., 2006). 
However, a higher odds of respiratory disease for calves reared in groups when 
compared to single-calf pen was reported by Svensson et al. (2003), and rearing calves 
in groups increases the risk of pathogen transmission (Warnick et al., 1977).  
 Regardless of the heifer-raising system, antimicrobials are widely used to 
prevent and treat BRD. A common practice in feedlot herd health programs is the use 
of antimicrobial metaphylaxis to prevent BRD (Jim et al., 1999; Schunicht et al., 
2002); the use of tilmicosin metaphylaxis on high-risk feedlot cattle was reported to 
reduce BRD incidence by 14% (Vogel et al., 1998). Additionally, studies have shown 
that administration of tilmicosin and florfenicol during the pre-shipping period in 
feedlot cattle can effectively inhibit Mannheimia haemolytica from colonizing the 
nasopharynx, suggesting that pre-shipment administration might reduce early onset of 
acute BRD (Frank and Duff, 2000).  
 As group-housed calf-rearing systems become more popular, it is expected that 
respiratory diseases will become more prevalent during the pre-weaning period. 
Therefore, the primary objective of this study was to evaluate the metaphylactic use of 
a synthetic long acting macrolide (tildipirosin) on the incidence of BRD, otitis, and 
survival in pre-weaned group-housed dairy calves that were fed unrestricted acidified 
milk. A secondary objective was to evaluate the effect of treatments on average daily 
gain (ADG).  
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MATERIALS AND METHODS 
Animals and Facility 
The study protocol was approved by the Institutional Animal Care and Use 
Committee of Cornell University (Protocol number 2013-0078). Assuming a type I 
error rate of 5%, a power of 80%, a two-sided statistical test, and a baseline 
probability of respiratory disease of 25%, a sample size of 250 calves per group was 
anticipated to detect a 10% reduction in the incidence of respiratory disease between 
the treatment and the control group. 
 The study was conducted from November of 2013 until June 2014 in a 
commercial dairy farm in upstate New York. Immediately after parturition, newborn 
calves were removed from the maternity pen and placed into a newborn pen bedded 
with dry sawdust and heated with heating lamps from November to March. All calves 
were fed approximately 4 L of raw pooled colostrum within 4 h of birth by esophageal 
feeder (Oral Calf Feeder Bag with Probe, Jorvet). Twice daily, newborn calves were 
moved from the newborn pen to a green-house type of barn with positive ventilation 
composed of 27 identical group-pens (70 m
2
) bedded with straw. Twenty-five calves 
were placed in each pen; all calves remained in the same pen from day one of life until 
weaning (65 days of life). Birth weight and weight at weaning of all heifer calves were 
measured using a portable scale (Waypig-15, Vittetoe Inc.). 
 Blood samples were collected on day 3 of life for measurement of serum 
immunoglobulin-G using an ELISA kit (Bethyl Laboratories). Calves were fed 
unrestricted, acidified, non-saleable milk. Non-saleable milk was harvested twice daily 
and kept inside a stainless-steel tank at 5
o
C until acidification process. The 
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acidification was performed inside the sealed stainless-steel tank where the non-
saleable cold milk (5
o
C) was constantly mixed with organic acid (formic acid 20% 
vol/vol) until a pH of 4.5 was reached. Acidified milk was kept for 72 hours inside the 
stainless-steel tank after the acidification process. After 72 hours, acidified milk was 
then directed to a smaller stainless-steel tank responsible for heating (18.5
o
C) and 
supplying each pen-feeder with constant acidified milk. Each feeder was comprised of 
6 nipples for a pen of 25 calves. All calves in this study were weaned by reducing the 
time of milk availability starting on day 55. After day 55 of life, the system was 
automatically set-up to reduce milk availability; gradual reduction of time was 
performed for 10 days until the complete absence of milk at 65 days of life. 
 
Treatment administration 
 All heifer calves were randomly enrolled at birth into one of three treatment 
groups: 1) control group receiving no treatment (CTR), 2) one antibiotic injection 
administered at 10 days of life (M1), or 3) two antibiotic injections at 10 days and 35 
days of life (M2). Randomization to each treatment group was performed a priori 
using random function in Excel (Microsoft). For this study, a synthetic long acting 
macrolide, tildipirosin (Zuprevo, Merck Animal Health), was the antibiotic of choice 
for the metaphylactic approaches due to its fast absorption and distribution to lung 
tissue (Menge et al., 2012).  
 The label for tildipirosin use includes the control of respiratory disease in beef 
and non-lactating dairy cattle at high risk of developing BRD. Under the Animal 
Medicinal Drug Use Clarification Act, its extra-label use as a metaphylactic 
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medication for control of otitis is justified as no other medications are labeled for this 
use in dairy calves. 
   
Case definition  
 Bovine respiratory disease was defined when the following clinical signs were 
detected in a calf: cough, rectal temperature >39.5 °C, increased cranioventral lung 
sounds, or wheezes. Otitis was defined by observation of ear pain evidenced by head 
shaking, scratching or rubbing the ears, epiphora, ear droop, or signs of facial nerve 
paralysis, with or without fever (rectal temperature >39.5°C). The calf barn was 
visited daily by the research team; each pen was visually inspected to evaluate calf 
behavior (animal posture, feeding, and interaction with herd mates). If any abnormal 
behavior was detected, the animal was restrained inside the pen and a complete 
physical exam was performed. Following the diagnosis of BRD or otitis, animals were 
treated according to farm protocols. 
 
Statistical Analysis 
Descriptive statistics were performed using the FREQ, MEANS, and 
UNIVARIATE procedures of SAS (SAS Institute INC., Cary, NC). Differences in 
initial body weight, serum IgG concentration at 3 days of life, diarrhea events 
before10 days of age, proportion of calves born to primiparous cows, calving location 
(free-stall or maternity),  and parturition difficulty (assisted or non-assisted) were 
evaluated between treatment groups. 
Four different Cox Proportional Hazard models using the proportional hazard 
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regression procedure in SAS were used to evaluate the effect of metaphylaxis on calf 
survival, BRD, otitis, and the combined incidence of BRD and otitis. The independent 
variables offered were: treatment group (CTR, M1, and M2), birth weight quartile, 
serum IgG, diarrhea events before 10 days of life, dam parity (first, second, and third 
or greater lactation), calving location (free stall or maternity), and parturition difficulty 
(assisted or non-assisted). Treatment was the only variable forced into the models.  
For all four Proportional Hazard Models, the final model was built using a 
backward stepwise selection of independent variables with a P-value < 0.05. Two-way 
interactions between remaining effects (including treatment) were tested and remained 
in the model if the P-value of < 0.05 was observed. To account for the effect of 
cluster, proportional hazard models were fitted using pen as a cluster (ID statement in 
SAS). Models proportional hazard assumptions were assessed based on a 
Kolmogorov-type Supremum test (ASSESS statement in SAS). 
The effect of treatment and disease on ADG was evaluated by two similar 
general linear models using the MIXED procedure of SAS. Least square means and 
respective standard error of the mean were estimated for all categorical main effects. 
Pen was used as a random effect in both models. Average daily gain was calculated by 
subtracting the body weight at weaning from the birth weight and subsequently 
dividing by the total days from birth to weaning.  
To evaluate the effect of treatment on ADG, the model was fitted to the data 
using the following independent variables: treatment group (CTR, M1, and M2), 
serum IgG, diarrhea events before 10 days of life, dam parity (first, second, and third 
or greater lactation), calving location (free stall or maternity), and parturition difficulty 
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(assisted or non-assisted). To evaluate the effect of disease (BRD and otitis) on ADG, 
the model was fitted to the data using the following independent variables: BRD (yes 
or no), otitis (yes or no), serum IgG, diarrhea events before 10 days of life, dam parity 
(first, second, and third or greater lactation), calving location (free stall or maternity), 
and parturition difficulty (assisted or non-assisted).  
For both models, biologically meaningful interactions were offered and 
retained in the model when a P-value < 0.05 was observed. Residual distribution was 
assessed for homoscedasticity and normality. Statistical significance was declared at P 
≤ 0.05 and statistical tendencies declared at 0.05 < P ≤ 0.10.  
 
RESULTS 
A total of 795 Holstein heifer calves were enrolled into the study. Descriptive 
statistics regarding calf- and dam-related events are presented in Table 5.1.  
Results of Cox proportional hazard models regarding effect of treatment group 
on mortality, BRD, otitis, and combined incidence of BRD and otitis are in Table 5.2. 
Mortality was not significantly different between treatment groups (P = 0.21). A 
tendency to have lower hazard of BRD was observed for M1 (HR = 0.68, P = 0.07) 
when compared to CTR group. Calves in M2 group also tended to have a lower hazard 
of BRD when compared to CTR group (HR = 0.70, P = 0.09). Additionally, a 
significantly lower hazard of having the combine BRD and otitis events was observed 
for M1 (HR = 0.70, P = 0.009) and M2 (HR = 0.72, P = 0.01). 
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Table 5.1: Descriptive statistics regarding number of calves, calves born from 
primiparous dams, assisted parturition, calving location, failure of transfer of passive 
immunity (serum IgG < 1,000 mg/dL), incidence of diarrhea before 10 days of life, 
serum IgG, and calf birth weight in each treatment group for 795 calves. 
 
 CTR M1 M2
 
P-value 
n 257 265 273 
 Percentage  
Calves born to primiparous 48.6 49.8 49.4 0.87 
Parturition assistance 12.4 9.8 9.9 0.45 
Maternity pen calving 88.5 89.2 89.1 0.55 
FTP
 
5.6 6.0 7.7 0.75 
Incidence of diarrhea  12.3 12.9 11.9 0.83 
 Mean (SEM)  
Serum IgG, mg/dL 1,56 (33.8) 1,49 (32.8) 1,56 (31.7) 0.27 
Birth weight, kg 38.2 (0.26) 38.5 (0.26) 38.0 (0.25) 0.36 
CTR, control group 
M1, tildipirosin metaphylaxis at 10 days of life 
M2, tildipirosin metaphylaxis at 10 and 35 days of life 
FTP, Failure of transfer of passive immunity 
 
Table 5.2: The effect of tildipirosin metaphylaxis on survival, bovine respiratory 
disease (BRD), otitis, and combined incidence of BRD and otitis in 795 pre-weaning 
dairy heifers were evaluated by 4 similar Cox`s proportional hazard models.  
 
  Hazard Ratio (95% Confidence Limits) P-value 
Mortality 
CTR
 
Ref.  
M1
 
0.51 (0.30 – 1.13) 0.11 
M2
 
0.62 (0.28 – 1.29) 0.21 
BRD 
CTR Ref.  
M1 0.68 (0.47 – 0.97) 0.07 
M2 0.70 (0.49 – 1.01) 0.09 
Otitis 
CTR Ref.  
M1 0.85 (0.67 – 1.23) 0.34 
M2 0.80 (0.62 – 1.15) 0.30 
Combined BRD and Otitis 
CTR Ref.  
M1 0.70 (0.58 – 0.95) 0.009 
M2 0.72 (0.60 – 0.98) 0.01 
CTR, control group 
M1, tildipirosin metaphylaxis at 10 days of life 
M2, tildipirosin metaphylaxis at 10 and 35 days of life 
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Metaphylaxis did not affect ADG (P = 0.55, Table 5.3). However, lower ADG 
were observed for calves born from primiparous dams (0.62 kg/day, ± 0.01, P < 0.001) 
and calves born weighing less than 35.8 kg (0.60 kg/day, ± 0.02, P = 0.01).  
 
Table 5.3: The effect of tildipirosin metaphylaxis on calf average daily weight gain 
(ADG, kg/day) in 795 group-housed Holstein dairy heifers raised under unrestricted 
acidified non-saleable milk. Data are presented as least square means (LSM) and 
standard error of the mean (SEM). 
 
  ADG (kg/day)
 
 
  LSM
 
SEM P-value 
Metaphylaxis CTR
 
0.63  0.01 
0.55 M1
 
0.64 0.01 
M2
 
0.65 0.01 
Parity of the dam
 
1
st
 0.62 0.01 
< 0.001 2
nd
  0.62 0.02 
3
rd
  0.69 0.02 
Birth weight, kg
 
<35.8 0.60 0.02 
0.01 
35.8 to 38 0.65 0.02 
38 to 40.8 0.65 0.02 
>40.8 0.66 0.02 
CTR, control group 
M1, tildipirosin metaphylaxis at 10 days of life 
M2, tildipirosin metaphylaxis at 10 and 35 days of life 
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 The effect of disease on ADG was also evaluated (Table 5.4). Calves affected 
with BRD had a lower ADG when compared to calves not affected with BRD (P = 
0.007). Calves affected with otitis also had impaired growth when compared to 
healthy calves (P < 0.001). Moreover, calves that were affected with both BRD and 
otitis had lower ADG during the pre-weaning period (P < 0.001). 
 
Table 5.4: General linear mixed models evaluating the effect of disease (bovine 
respiratory disease and otitis) on calf average daily weight gain (ADG, kg/day) in 795 
group-housed Holstein dairy heifers raised under unrestricted acidified non-saleable 
milk. Data are presented as least square means (LSM) and standard error of the mean 
(SEM). 
 
  
ADG (kg/day) 
P-value 
  
LSM SEM 
Birth weight, kg <35.8 0.58 0.02 
0.004 
35.8 to 38 0.64 0.02 
38 to 40.8 0.63 0.01 
>40.8 0.66 0.02 
Parity of the dam 1
st
 0.59 0.01 
0.001 2
nd
  0.62 0.02 
3
rd
  0.67 0.02 
Bovine respiratory disease Affected 0.60 0.02 
0.007 
Not affected 0.65 0.01 
Otitis Affected 0.60 0.02 
0.001 
Not affected 0.66 0.01 
 
 
  
 141 
DISCUSSION 
 Two metaphylactic approaches were evaluated in a commercial dairy farm 
where dairy heifer calves were raised in group-pens of 25 calves per pen and fed 
unrestricted, acidified, non-saleable milk. Metaphylaxis treatments were performed 
using a semi-synthetic macrolide (tildipirosin) injected at 10 days of life (M1) and a 
second group receiving two injections one at 10 and another at 35 days of life (M2). 
Metaphylaxis treatments had significantly lower hazard of the combined events of 
BRD and otitis during the pre-weaning period. However, only a tendency was 
observed when only BRD was evaluated, and no effect of treatment was observed for 
calves affected only with otitis. Additionally, metaphylaxis treatments did not affect 
ADG during the pre-weaning period.   
 The majority of the research regarding metaphylactic approaches against BRD 
has been conducted in feedlot cattle where the incidence of BRD fluctuates between 
20% and 50% (Booker et al., 2007; Menge et al., 2012). However, lower incidences 
were observed in studies conducted on dairy heifers which ranged from 10% to 25% 
during the first 3 months of life (Sivula et al., 1999; Virtala et al., 1999; Bach et al. 
2011).  
 In contrast to the extensive peer-reviewed literature regarding metaphylaxis 
approaches in feedlot cattle, to the best of our knowledge, only one study evaluating 
antimicrobial metaphylaxis has been conducted on pre-weaned dairy calves. Stanton et 
al. (2013) conducted a study on a heifer-raising facility to evaluate the effect of 
metaphylaxis (tulathromycin) at 3 (±2) days of life on the incidence of BRD. In that 
study, Stanton et al. (2013) reported that metaphylactic treatment had no effect on 
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BRD (only 2% of calves in the treatment group were affected with BRD and 3% in the 
control group). It is important to highlight that in the study conducted by Stanton et al. 
(2013), heifer calves originated from 5 different commercial dairy farms and once in 
the heifer raising facility, calves were individually allocated in 1 out of 6 naturally 
ventilated barns or in 47 individual outdoor hutches and fed 4L/feeding of milk 
replacer twice daily.  
 Similarly, tildipirosin metaphylaxis in the present study had no effect on BRD 
incidence during the pre-weaning period in Holstein heifer calves reared under an 
unrestricted, acidified, non-saleable milk regime and in groups of 25 calves per pen. 
Likewise, metaphylaxis had no effect on otitis prevention during the pre-weaning 
period in the present study. Otitis was diagnosed in 33.5%, 32.4%, and 30% of the 
calves enrolled in the CTR, M1, and M2 groups, respectively. Stanton et al., (2013) 
reported a significant effect of tulathromycin metaphylaxis on unilateral and bilateral 
ears droop reduction when compared to control calves.  
 Otitis and BRD are frequently concomitant diseases, sharing common risk 
factors and similar pathogens (Yeruham et al., 1999; Francoz et al., 2004) such as 
Mycoplasma bovis (Lerner et al., 2014), Haemophilus somnus (Walz et al., 1997), 
Pasteurella multocida (Nation et al., 1983), and Mannheimia haemolytica (Jensen et 
al., 1983). In the current study, although no effect on BRD or otitis was found with 
metaphylactic treatment, a protective effect was observed for the combined incidence 
of BRD and/or otitis during the pre-weaning period, likely due to early protection 
against some of the common pathogens associated with otitis and BRD. 
There are many risk factors reported to be associated with BRD such as group 
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size (Svensson et al. 2006), birth season (Dennis, 1986), colostrum management 
(Donovan et al. 1998), and dam parity (Perez et al., 1990). Lombart et al. (2007) 
reported that calves born from severe dystocia had higher odds of receiving a 
treatment for BRD during the first 120 days of life. Additionally, a recent study 
evaluated the association between several risk factors with an increased risk of BRD in 
19 herds in Canada and USA. The risk factors that significantly increased BRD 
incidence were herd-level incidence of BRD, season of birth (31.8% during the winter 
and 15.2% during the summer), navel dipping, other diseases before 2 weeks of age, 
failure of transfer of passive immunity, and manual control of temperature in pre-
weaning housing (Windeyer et al., 2014). In the present study, for all the models 
evaluating the effect of treatment on BRD and otitis morbidity as well as mortality, 
neither calving assistance, parity of the dam, nor calving location were significantly 
associated with increased risk of BRD or mortality. 
 A prospective observational cohort study conducted by Sivula et al. (1999) 
reported an association between calves with failure of transfer of passive immunity 
(serum IgG concentration < 800 mg/dL) and an increased risk of mortality and BRD. 
In the present study, failure of transfer of passive immunity was defined as a serum 
IgG concentration at 3 days of life < 1,000 mg/dL and was below 8% in all treatment 
groups. Besides the method of assessing adequate transfer of passive immunity on 
newborn calves, using total serum solids (> 5.5 g/dL) or enzyme-linked 
immunosorbent assay (IgG > 1000mg/dL), numerous studies have reported adverse 
effects of failure of transfer of passive immunity on heifer mortality, health, and post-
weaning performance (Faber et al., 2005; Priestley et al., 2013; Windeyer et al., 2014). 
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However, in this study, failure of passive transfer was not found to be significantly 
associated with mortality, morbidity, and ADG during the pre-weaning period. 
 In the present study, metaphylaxis did not affect ADG during the pre-weaning 
period but dam parity and birth weight quartiles did. Calves born to primiparous cows 
and calves in the lowest birth weight quartile had the lowest ADG, while calves born 
to cows at third or greater parity and calves in the highest birth weight quartile had the 
highest ADG during the pre-weaning period. Sivula et al. (1996), reported comparable 
results as ADG significantly increased with parity of the dam. Similarly, a study on 
2,491 calves followed to 180 days of life conducted by Simensen and Norheim (1983) 
reported calves born to first parity dams had the smallest chest girth at 180 days of life 
while calves born to third parity or greater dams had the largest measurements. Parity 
can also affect the birth weight, as a study reported birth weights of female calves born 
to second and third lactation cows to be approximately 8% heavier when compared to 
primiparous cows (Kertz et al., 1997). Birth weight of heifer calves was elsewhere 
reported to impair ADG, where calves lighter at birth gained significantly less weight 
by weaning (Teixeira et al., 2013).  
 Here we observed that calves affected with BRD had significantly lower ADG 
during the pre-weaning period compared to healthy calves. The effect of calfhood 
disease (diarrhea, septicemia, and respiratory disease) has been consistently associated 
with lower ADG in many studies. Virtala et al. (1996) reported that calves diagnosed 
and treated for BRD had lower ADG in the first month of life compared to healthy 
calves, and the negative effect of calf morbidity (BRD and diarrhea) on growth rate 
from birth to 90 days of life was reported by Lundborg et al. (2003). Ganaba et al. 
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(1995) reported that calves diagnosed with diarrhea or respiratory disease during their 
first 2 weeks of life had lower growth rates, and Donovan et al. (1998) reported that 
diarrhea, septicemia, or BRD before weaning reduced the weight of 6 month-old 
calves by 4.8 to 10.6 kg.  
 Similar to BRD, we found that significantly lower ADG were observed for 
calves affected with otitis when compared to healthy calves during the pre-weaning 
period; calves affected with otitis had on average a 60.1 g/day reduction in weight gain 
during the pre-weaning period compared to healthy calves. This effect has varied in 
previous studies. Stanton et al. (2013), when evaluating the effect of disease in ADG 
during the pre-weaning period, reported a 50 (±20) g/day difference between calves 
affected with unilateral ear droop compared to calves without ear droop; however, the 
ADG was not different between calves affected with bilateral ear droop when 
compared to calves without ear droop. Contrarily, Pardon et al. (2012), when 
evaluating the impact of BRD, diarrhea, otitis and arthritis on carcass traits in white 
veal calves, found no significant association between otitis and hot carcass weight.  
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CONCLUSIONS 
 Tildipirosin metaphylaxis treatment had no effect on mortality, otitis, and 
ADG during the pre-weaning period; however, a tendency to have lower hazard of 
BRD was reported for calves receiving metaphylaxis treatment. When evaluating the 
combined incidence of BRD and otitis, tildipirosin metaphylaxis significantly reduced 
disease incidence. Long-acting antibiotic metaphylaxis could be strategically used to 
decrease the combined incidence of BRD and otitis in high-risk group-housed 
replacement heifers during the pre-weaning period. 
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ABSTRACT 
 The objective of this study was to determine the association of lung 
consolidation at weaning with later reproductive performance and survival. 
Ultrasonography of the lungs was performed at 60 d of life in recently weaned 
Holstein heifer calves from a single farm in New York State. Thoracic screening 
covered the right 2
nd
 through 10
th
 and left 3
rd
 through 9
th
 intercostal spaces and was 
performed using a 6.2 MHz linear transducer. Each calf was classified as not having 
lung consolidation (NC; hyperechoic line with reverberation artifact with or without 
comet tail) or with lung consolidation (LC; any detectable heterogeneous hypoechoic 
area). A total of 613 heifer calves were enrolled in the study, with 489 (79.8%) 
classified as NC and 124 (20.2%) classified as LC.  
 No difference in mortality was observed from 60 to 350 d of life between 
heifers with lung consolidation (1.6%) and without lung consolidation (2.0%). Six 
hundred and one nulliparous Holsteins became eligible for insemination at 350 d of 
life; there was a higher hazard of being removed from the herd between 350 d of life 
and first calving for heifers with lung consolidation at weaning (hazard ratio = 4.7, 
95% confidence interval = 2.1 to 10.7). Additionally, heifers without lung 
consolidation tended to have improved pregnancy to first AI (62.0%) compared to 
heifers with lung consolidation (52.5%). Overall reproductive performance was also 
affected as heifers with lung consolidation at 60 d of life had a lower hazard of 
pregnancy compared to those without lung consolidation (hazard ratio = 0.7, 95% 
confidence interval = 0.6 to 0.8).  
 From 601 animals that the breeding period, 565 entered the milking herd and 
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were followed during the first 3 months of lactation. No differences in weekly average 
milk production were observed between animals with or without lung consolidation at 
weaning.  
 Our results show that heifers with lung consolidation at weaning were less 
likely to get pregnant and more likely to be culled before their first parturition than 
heifers without lung consolidation; this difference did not continue into first lactation 
milk production, risk of culling, or reproductive performance.  
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INTRODUCTION 
 Bovine respiratory disease (BRD) affects approximately 16% of pre-weaned 
heifers in the United States, of which 90.2% of BRD affected pre-weaned heifers are 
treated with antibiotic (USDA, 2012), leading to impaired survival and reproductive 
performance (Stanton et al., 2012). There is currently no gold standard for BRD 
diagnosis, and researchers have developed two useful respiratory scoring charts to 
assist with detection and treatment of BRD (McGuirk, 2008; Love et al., 2014). In 
addition to these subjective measures, thoracic ultrasound has been proposed as a 
useful calf-side tool to improve quantitative diagnosis of BRD (Buczinski et al., 2013; 
Buczinski et al., 2014). Studies assessing the sensitivity and specificity of thoracic 
ultrasound in diagnosing BRD, where BRD was confirmed by necropsy, reported a 
sensitivity of 86% to 94% and a specificity of 98% to 100% (Rabeling et al., 1998; 
Ollivett et al., 2015). It is important to note that in the Rabeling study only clinical 
cases were evaluated and that the Ollivett study had a small number of animals. 
Thoracic ultrasound has been proposed as a calf-side tool to aid BRD diagnosis, detect 
pulmonary lesions, and reduce use of antimicrobials (Jung and Bostedt, 2004; Ollivett 
et al., 2011).   
 The extent to which lung lesions, confirmed at slaughter, can impair 
subsequent productivity has been assessed by multiple studies in the feedlot cattle. 
These studies found lower weight gain during feeding, a high incidence and lower 
weight gain in subclinical (never diagnosed or treated) BRD animals, and economical 
losses ranging from $1.79 per animal entering the feedlot, to approximately $54 for 
animals presenting lesions at slaughter and recurrent BRD treatments (Thompson et 
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al., 2006; Schneider et al., 2009). In contrast, results regarding the impact of 
pulmonary lesions on milk production and reproductive performance of dairy animals 
are scarce. To our knowledge, only one study has been conducted that correlates lung 
lesions in dairy cattle to performance (Adams and Buczinski, 2016). In this study, lung 
consolidation was assessed using thoracic ultrasonography in three-month old Jersey 
heifers. They reported that heifers with extensive consolidation had a higher risk of 
being removed from the herd between 80 and 330 d of life but did not find a 
significant impact of lung score to age at first calving. While few studies have 
evaluated pulmonary lesions, more have reported detrimental effects of early life 
diagnosis of BRD on performance through the first lactation, higher risk of herd 
removal, and delayed age at first calving (Bach, 2011; Stanton et al., 2012).  
 Given the limited knowledge surrounding pulmonary lesions in dairy heifers 
and their association with production outcomes, our objective was to explore the 
consequences of lung consolidation in dairy heifers at weaning with subsequent 
survival and reproductive performance. For this prospective cohort study, we 
hypothesized that heifer calves with lung consolidation at weaning would have higher 
age at pregnancy and a higher culling risk when compared to herd mates without lung 
consolidation. A secondary objective was to investigate the association of lung 
consolidation at weaning with weekly milk average, risk of culling, and risk of 
pregnancy to first service within the first 3 months of first lactation.  
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MATERIALS AND METHODS 
 The study was conducted on a commercial dairy farm located near Ithaca, New 
York from November 2013 until February 2014. The study was approved by the 
Institutional Animal care and Use Committee of Cornell University (protocol number 
2013-0076).  
 
Pre-weaning Management 
 This study was conducted in a commercial dairy farm milking approximately 
3,700 Holstein cows, near Ithaca, NY. Newborn Holstein dairy heifers were fed 4 L of 
pooled pasteurized colostrum via esophageal tube within 4 h after birth and moved 
daily from the maternity pen to the pre-weaning calf barn. Pre-weaning heifers were 
housed in a green-house type barn with positive ventilation composed of 10 identical 
group-pens (85 m
2
) bedded with straw. Twenty-five calves were placed in each pen; 
all calves remained in the same pen from d one of life until weaning at 60 d of life.  
 All heifer calves were fed unrestricted, acidified, non-saleable milk. 
Acidification was performed inside a sealed stainless-steel tank where the non-
saleable cold milk (5
o
C) was constantly mixed with organic acid until a pH of 4.5 was 
reached. Acidified milk was kept for 72 h inside the stainless-steel tank after the 
acidification process was finished. Milk was then directed to a smaller stainless-steel 
tank responsible for heating (18.5
o
C) and supplying each pen-feeder with constant 
acidified milk. Each feeder was comprised of 6 nipples for a pen of 25 calves. All 
calves in this study were weaned by reducing the time of milk availability starting on d 
55; a gradual reduction of time was performed for 5 d until the complete absence of 
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milk at 60 d of life. 
   
Lung Ultrasonography 
 One member of the research team was responsible for performing lung 
ultrasonography on all calves at 60 d of life. A structure was built using stainless steel 
bars in a gate-like “U” layout (3 parts); the structure was fixed inside each pen (1.5m x 
0.75m) by latching one end to the gate pen which allowed for single calf isolation 
where ultrasonographic exams were performed. This structure was washed and used 
for the next pen by the time of thoracic ultrasound examination. Thoracic ultrasound 
examinations were carried out using an Ibex-pro device with a 6.2 MHz linear 
transducer (E.I. Medical Imaging). Examination of the lung areas was performed by 
screening dorsal to ventral intercostal spaces from the right 2
nd
 through 10
th
 and left 3
rd
 
through 9
th
 intercostal spaces. The first intercostal space of the right side was not 
included in the examination because examiner could not consistently reach 1
st
 
intercostal space for all the calves examined. Calves were not shaved in any area on 
the thorax; to achieve better contact and imaging quality, 70% isopropyl alcohol was 
applied to the haired areas under examination. 
 The scoring procedure used in this study was an adaptation from Ollivett et al., 
2011. Thoracic ultrasound was performed on each hemithorax for all calves and a 2 
point-scale assigned: no lung consolidation (NC) or with any detectable lung 
consolidation (LC). Animals received one score based on the combined exam of the 
right and left thoracic area. Each exam required approximately 5 min per calf. Heifers 
were classified as NC if no abnormalities were detected on thoracic ultrasound, i.e. 
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well-ventilated peripheral lung tissue (hyperechoic line with reverberation artifact) or 
comet-tails artifacts observed in one or multiple lobes (hyperechoic vertical lines 
originated from the aerated lung surface). Heifers were classified as LC if a detectable 
consolidation was observed, meaning any size consolidation (heterogeneous 
hypoechoic area without the clear line of the pleural surface) detected in one or more 
lung lobes (Figure 6.1).  
 
 
Figure 6.1: Ultrasonographic evidence of heifers with no consolidation (NC; well-
ventilated peripheral lung tissue represented by hyperechoic line with reverberation 
artifact or with comet-tails artifacts observed in one or multiple lobes represented by 
hyperechoic vertical lines originated from the aerated lung surface) and heifers with 
detectable consolidation (LC; any detectable consolidation represented by a 
heterogeneous hypoechoic area without the clear line of the pleural surface was 
detected in one or more lung lobes). Each square is 1 cm
2
.  
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Post-weaning Management 
  After thoracic ultrasound, heifers were moved to a post-weaning pen. Weaned 
heifer pens were fed TMR daily to maintain a weight gain of approximately 0.9 kg/d 
(NRC, 2001). Vaccination against infectious bovine rhinotracheitis virus, bovine viral 
diarrhea virus (types 1 and 2), bovine respiratory syncytial virus, parainfluenza-3 
virus, and clostridial diseases were performed at 3 months of age (Vista 5 SQ and 
Covexin 8, Merck Animal Health). Heifers were moved weekly to breeding pens 
around 350 d of life. Once in the breeding pens, heifers were allowed 30 d of artificial 
insemination upon estrus detection before receiving an injection of prostaglandin 
followed by estrus detection. Heifers not detected in estrus were given a repeat 
prostaglandin injection every 2 weeks until 550 days of life. Pregnancy diagnoses 
were performed by veterinarians for inseminated animals between 35 and 41 d post-
AI. Pregnancy diagnoses were confirmed by a re-check performed between 61 and 74 
d post-AI. Starting at approximately 240 d of gestation, heifers were moved weekly 
from the breeding pens to a close-up pen where animals were more closely monitored 
by farm employees. Pregnant animals detected in stage 1 or 2 of parturition were 
moved to the maternity pen. After calving, primiparous cows were milked at the 
maternity pen and then moved to a fresh cow pen within 6 hours of first milking. 
Primiparous fresh cows were milked 3 times per d in a 100-stall rotary parlor. All 
lactating animals were offered TMR formulated to meet or exceed the National 
Research Council nutrient requirements (NRC, 2001) for lactating Holstein cows 
weighing 650 kg and producing 45 kg of 3.5% fat corrected milk. 
  A voluntary waiting period of 50 d was used for primiparous cows. The 
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reproductive management for first lactation cows utilized a combination of Presynch, 
Ovsynch, Resynch, and detection of estrus, with approximately 30% of cows bred via 
timed artificial insemination (TAI) and the remainder bred after detection of estrus 
solely by activity monitors (Alpro, DeLaval). Briefly, the protocol for first 
insemination utilized two injections of prostaglandin administered 14 d apart for pre-
synchronization, followed by the Ovsynch-56 protocol 7 d later to facilitate TAI. 
Animals detected in estrus after the second prostaglandin injection through the start of 
the Ovsynch protocol were inseminated. Pregnancy diagnoses for primiparous cows 
were performed for inseminated animals between 35 and 41 d post-AI and confirmed 
by a re-check performed between 61 and 67 d post-AI. 
 Animals were followed until the first 90 DIM. Post-partum diseases were 
diagnosed by trained farm employees; retained placenta was noted for animals that 
retained fetal membranes >24 hours after parturition, metritis was recorded for 
animals with fetid watery red-brown uterine discharge with or without fever within 21 
d post-partum, and clinical mastitis noted as animals with at least one quarter 
presenting abnormal milk. Treatments were performed according to farm protocols. 
   
Statistical Analyses 
 A priori sample size calculation was performed based on a 10% difference in 
survival rate between heifers without lung consolidation (0.95) and heifers with lung 
consolidation (0.85). Expecting that lung consolidation would be detected by the end 
of the weaning period in one out of 10 heifers, with a probability of Type I error of 
0.05 and a power of 0.80, a total of 600 heifers were enrolled in this study.  
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 The data retrieved from the farm's computer software (DairyComp 305 Valley 
Agricultural Software) included: age at first breeding, age at conception (defined after 
pregnancy diagnosis confirmation at approximately 60 d of gestation, back calculated 
to the number of d from birth to the d of conception), removal from herd (including 
death and animals that were sold), pregnancy risk to first service (percent of animals 
pregnant to the first artificial insemination), pregnancy length, age at first parturition, 
abortions (gestation length <260 d), twins, stillbirth, assisted or non-assisted 
parturition, and offspring birth weight (measured before colostrum feeding by farm 
employees using a dedicated scale; Waypig Digital 500, Raytec). First lactation data 
regarding average weekly milk production were collected until 90 DIM. Data 
regarding post-partum diseases (retained placenta, metritis, and clinical mastitis) were 
also retrieved from farm records.  
 Descriptive statistics regarding differences between lung score category (NC 
versus LC) and the normally distributed continuous variables (age at first breeding, 
age at first calving, gestation length, and offspring weight at birth) were performed 
using two-sided t-tests.  Chi-square tests were used to compare the risk of pregnancy 
to first service, abortion, stillbirth, twinning, and assisted parturition between lung 
consolidation groups (TTEST and FREQ procedures in SAS; version 9.4, SAS 
Institute Inc.). 
 To assess the association of lung score with survival and reproductive 
performance, two similar Kaplan-Meier time-to-event models were fitted using the 
LIFETEST procedure in SAS. For the culling analysis animals were censored on the d 
of herd removal regardless of reason (animals that died or were sold) or right-censored 
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on the d of parturition. For the reproductive performance analysis (n = 601), heifers 
were censored at age at conception or right-censored at time of herd removal for 
animals that were never confirmed pregnant. The last pregnant animal calved at 840 d 
of life, which was then considered the end of the evaluation period. Since no animals 
were removed from the herd after 550 d, the time-to-event was arbitrary limited to 740 
d of life. Kaplan-Meier plots were created using MedCalc (Version 16.4.3, MedCalc 
Software, BVBA). 
 For animals entering the milking herd (n = 565), differences in the number of 
animals in each cohort based on lung consolidation, proportion of primiparous animals 
diagnosed pregnant at first service (n = 546), incidence of retained placenta (n = 565), 
metritis (n = 565), and clinical mastitis (n = 565) tests were performed using the 
FREQ (chi-square test) and TTEST (two-sided t-test) procedures in SAS. 
Additionally, two similar Kaplan-Meier models were used to evaluate the association 
of lung ultrasonography performed at 60 d of life with primiparous reproductive 
performance (n = 546) and survival for the first 90 DIM (n = 565). 
 Weekly milk production data were collected for the first 90 DIM from all the 
cows entering the milking herd (n = 565). Average weekly milk production for the 
first 90 DIM was assessed using repeated-measures ANOVA with the MIXED 
procedure of SAS and an autoregressive covariance structure. Animal within lung 
consolidation group was treated as a random effect, and thoracic ultrasound score (NC 
or LC) and week in milk (1 to 12) were treated as covariates. Least square means and 
standard errors (SE) were estimated and reported. Model fit was assessed by visually 
evaluating the distribution plot of the Studentized residuals. For this model, 
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Bonferroni correction for multiple comparisons was used. Statistical significance was 
declared at P ≤ 0.05, and statistical tendencies at 0.05 < P ≤ 0.10.  
  
RESULTS 
A total of 613 heifer calves were enrolled in the study, with 489 (79.8%) 
classified as NC and 124 (20.2%) classified as LC. From 60 to 350 d of life, 1.6% of 
animals in the LC group and 2.0% of animals in the NC group were removed from the 
herd (P = 0.74). Thus, the total number of animals remaining in the study at 350 d of 
life was 601.  
For 601 animals entering the reproduction phase, survival was evaluated from 
350 d of life to age at calving (Figure 6.2). The proportion of animals culled in the LC 
cohort was 15.6% and 3.5% for the NC cohort during this period. A higher hazard of 
death was observed in LC than NC heifers (hazard ratio (HR) = 4.7, 95% CI = 2.1 to 
10.7, P < 0.001).  
Additionally, LC heifers had a lower hazard of pregnancy when compared to 
NC heifers (HR = 0.7, 95% CI = 0.6 to 0.8, P = 0.006, Figure 6.3). No differences in 
age at first breeding were observed between the two cohorts. However, age at first 
calving was significantly lower in NC heifers than LC heifers (P = 0.04, Table 6.1). A 
tendency for lower pregnancy risk to first service was observed in LC heifers 
diagnosed with lung consolidation (52.5%) when compared to NC heifers (62.0%, P = 
0.06). 
From 601 heifers that entered the reproduction phase at 350 d of life, 565 
pregnant heifers calved and entered the milking herd. No differences were observed 
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for any of the other variables: gestation length, stillborn, twins, abortions, assisted 
parturition, and offspring birth weight (Table 6.1).  
 
Table 6.1: Thoracic ultrasonography was performed at 60 days of life and heifers 
were classified as; no lung consolidation (only clear pleural surfaces or comet tails 
were observed, solid line) or lung consolidation (any detectable consolidation in one 
or more lung lobes, dashed line). Table regarding age at first breeding, age at first 
calving, gestation length, offspring weight, percentage of pregnancy to first service, 
abortion, stillbirth, twins, and assisted parturition between heifer with and without 
lung consolidation. 
 
 
No lung consolidation Lung consolidation P-value 
 Mean (SE) Mean (SE)  
Age at first breeding, d 386.7 (0.6) 386.0 (1.0) 0.42 
Age at first calving, d 679.8 (1.4) 687.4 (2.0) 0.04 
Gestation length, d 277.6 (0.2) 277.2 (0.5) 0.48 
Offspring weight, kg 37.5 (0.2) 37.4 (0.5) 0.76 
Pregnancy to first service, % 62.0 52.5 0.06 
Abortion, % 2.2 2.9 0.63 
Stillbirth, % 6.9 9.1 0.12 
Twins, % 2.7 2.5 0.69 
Assisted parturition, % 17.3 20.3 0.35 
 
 
No differences in survival were observed for primiparous cows between LC 
and NC animals between calving and the first 90 DIM. The hazard of culling was 1.0 
(95% CI = 0.5 to 2.1, P = 0.93). Moreover, only 546 primiparous cows that entered the 
milking herd were alive at 50 DIM (50 d of VWP). No differences in reproductive 
performance were observed between LC and NC animals; the hazard of pregnancy 
was 1.0 (95% CI = 0.7 to 1.4, P = 0.81). 
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Figure 6.2: Kaplan-Meier analysis of time to culling in 601 nulliparous Holstein 
heifers that underwent lung ultrasonography evaluation at 60 d of life. 
Ultrasonographic lung score of each thoracic ultrasound was evaluated in a 2 point-
scale defined as: no lung consolidation (only clear pleural surfaces or comet tails were 
observed, solid line) or lung consolidation (any detectable consolidation in one or 
more lung lobes, dashed line). Heifers with lung consolidation had a higher hazard of 
culling compared to heifers without lung consolidation (hazard ratio = 4.7, 95% CI = 
2.1 to 10.7, P < 0.001). 
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Figure 6.3: Kaplan-Meier analysis of time to pregnancy in 601 nulliparous Holstein 
heifers that underwent lung ultrasonography evaluation at 60 d of life. 
Ultrasonographic lung score of each thoracic ultrasound was evaluated in a 2 point-
scale defined as: no lung consolidation (only clear pleural surfaces or comet tails were 
observed, solid line) or lung consolidation (any detectable consolidation in one or 
more lung lobes, dashed line). Animals were followed from 350 d of life until age of 
confirmed pregnancy or removal from the herd. Heifers with lung consolidation had a 
lower hazard of being pregnant compared to heifers without lung consolidation 
(hazard ratio = 0.7, 95% CI = 0.6 to 0.8, P = 0.006). 
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No differences between incidences of post-partum diseases or pregnancy to 
first service were observed for primiparous cows. For 565 pregnant heifers that calved, 
no differences were found regarding the incidence of retained placenta (P = 0.15) 
between LC (6.0%) and NC (2.7%), incidence of metritis (P = 0.74) between LC 
(32.2%) and NC (30.6%), and incidence of clinical mastitis (P = 0.90) between LC 
(6.1%) and NC (5.8%). For 546 primiparous cows, no difference between pregnancy 
to first service was observed (P = 0.38) between LC (30.2%) and NC (26.8%).  
First lactation average weekly milk production data were collected. No 
differences were observed for the first 12 weeks of milk production between animals 
diagnosed with or without lung consolidation as heifers (P = 0.73).  
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DISCUSSION 
 To our knowledge, this is the first study evaluating the association of one-time 
thoracic ultrasound in replacement Holstein heifer calves and later performance. 
Although this is a single herd study, 613 heifer calves underwent thoracic ultrasound 
at 60 d of life in which 546 of these calves continued to be followed through 90 DIM. 
Heifers detected with lung consolidation at 60 d of life had a higher age at first 
calving, a higher hazard of death, and a lower hazard of pregnancy than heifers 
without lung consolidation. Additionally, a tendency for lower pregnancy to first 
service was reported for heifers with lung consolidation when compared to heifers 
without lung lesions. However, the effect of a one-time ultrasonographic evaluation at 
60 d of life seemed to have detrimental effects only before animals entered their first 
lactation. No differences were observed for post-partum disease incidences (retained 
placenta, metritis, and mastitis), reproductive performance, or survival in the first 90 
DIM between animals with lung consolidation or without consolidation at 60 d of life. 
  In a recently published study, 240 Jersey heifers had a single thoracic 
ultrasound at 96 ±6 d of life and were followed until age at calving or removal from 
the herd (Adams and Buczinski, 2016). Calves with at least one site of consolidation 
(≥ 6 cm), abscessation within the lung parenchyma, or significant pleural effusion (> 1 
cm) had a higher chance of being removed from the herd. Interestingly, the survival of 
Jersey heifers with limited extent of lung consolidation (consolidation between 1 and 6 
cm) was no different than heifers with no consolidation. In our study, heifers with no 
lung consolidation on thoracic ultrasound had better survival from 350 d of life to 
calving than calves showing any consolidation. The scoring system generated by 
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thoracic ultrasound in our study was simplified even further than others have proposed 
(Ollivett et al., 2011; Adams and Buczinski, 2016). Thoracic ultrasonography was 
performed in a stationary unit that allowed the examination of the right 2
nd
 through 
10
th
 and left 3
rd
 through 9
th
 intercostal spaces. In the present study, researchers were 
unable to include the ultrasound data from the 1
st
 intercostal space, this certainly 
decrease the researchers ability to detect possible consolidations present in the cranial 
aspect of the right cranial lobe, which can be inspected at the 1
st
 and 2
nd
 intercostal 
space on the right hemithorax (Ollivett et al., 2013). 
 Our observed outcomes for calves with lung consolidation at 60 d of life are in 
agreement with the deleterious effect of BRD detected before 90 d of age, specifically 
delayed age at first calving (Correa et al., 1988) and increased risk of death (Stanton et 
al., 2012). Additionally, poorer reproductive performance was reported for BRD 
treated calves before 60 d of life (Bach, 2011; Stanton et al., 2012). In the current 
study, because of the known subjectivity of BRD detection (Sivula et al., 1996), no 
attempt was made to retrieve farm data on BRD treatments. Two very useful charts are 
widely used as an on-farm tool to diagnose BRD (McGuirk, 2008; Love et al., 2014). 
Although chart driven systems are a good tool in helping caretakers to diagnose cases 
of BRD, they are still highly dependent of the ability of the caretaker to observe 
clinical signs; misclassification could lead to unnecessary use of antimicrobials and 
misleading data regarding BRD. 
 In the current study, Holstein heifers without lung consolidation at 60 d of life 
had 62.0% pregnancy to first service which is in agreement with data published 
elsewhere for Holstein heifers in United States (Ettema and Santos, 2004). However, a 
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tendency of lower pregnancy rate at first service (52.5%) was observed for heifers 
with lung consolidation. The reproductive performance results presented for 
nulliparous heifers might be attributed to a lower weight gain during the first 6 months 
as weight gain has previously been related to lung lesions in feedlot steers (Wittum et 
al., 1996). Delayed age at first calving and lower pregnancy risk at first service are 
frequently associated with suboptimal growth rates before 6 months of age (Brickell et 
al., 2009). However, no differences in age at first breeding between heifers with or 
without lung consolidation were observed in this study.  
 The thoracic ultrasonography technique used in our study can be performed in 
a relatively short time using a conventional linear probe and ultrasound. While no ante 
mortem calf-side gold standard tool to diagnose BRD exists, implementation of 
thoracic ultrasound should be considered by veterinarians in replacement heifer 
facilities; this practice can be used to detect heifers with higher risks of replacement 
failure. Different management practices can then be assigned to at-risk groups of 
heifers as needed, adjusting growth rates, pathogen screening, and selective use of 
antimicrobials. 
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CONCLUSIONS 
 As proposed by others that performed thoracic ultrasonography, the use of a 
calf-side tool to improve replacement heifer management should be further 
investigated using a larger number of animals and in different pre-weaning rearing 
systems. Although no detrimental effects of lung lesions at 60 d of life were observed 
for primiparous cows during the first 90 DIM into the first lactation, we found 
significant impacts for nulliparous heifers through a decrease in reproductive 
performance and an increase in culling risk. 
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FINAL CONSIDERATIONS 
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 The aim of this dissertation was to enrich the body of studies regarding 
calfhood disease prevention and control as well as assess alternatives to standard 
practices to raise replacement dairy heifers. We evaluated alternatives to common 
methods used to reduce bacterial contamination of colostrum and non-saleable milk 
(Chapter One) and further evaluated if early life injectable trace mineral 
supplementation would improve dairy heifers’ health and performance (Chapter Two). 
Neonatal enteritis or calf scour is commonly treated and prevented with the use of 
antimicrobials, and herein we tested if a natural product could be used to prevent water 
losses due to secretory diarrhea, decreasing the dehydration burden of scouring calves 
in a single pathogen challenge study (Chapter Three) and in a scenario mimicking 
farm conditions (Chapter Four). As group-housed calf-rearing systems have become 
more popular, respiratory disease has also become more prevalent during the pre-
weaning period. Therefore, two metaphylactic approaches were tested in a randomized 
clinical trial to test if high-risk dairy heifers would benefit from such intervention 
(Chapter Five). Finally, we investigated if pulmonary lesions caused by early events of 
pneumonia could impair replacement heifers’ productivity and reproductive 
performance (Chapter Six). 
 In chapter one, we conducted a block randomized clinical trial in a commercial 
dairy farm an attempt to test if ultraviolet light could be used as an alternative to heat 
treatment of colostrum and non-saleable milk. For this study, we hypothesized that the 
antimicrobial ultraviolet light properties could lead to decreased bacterial load (similar 
to heat treatment) without detrimental effects on immunoglobulins concentration 
(typical when using heat treatment). Data regarding incidence of diseases (respiratory 
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disease, otitis, and diarrhea) and body weight were recorded. Additionally, dam related 
events that could potentially affect calf performance (dystocia and health events 
around parturition) were also collected. In this first study, we observed that heat 
treatment was generally more effective than ultraviolet light in reducing bacterial 
count for both colostrum and non-saleable milk. More interestingly, we observed that 
ultraviolet light had a greater detrimental effect on the colostrum immunoglobulin 
content when compared to heat treatment of colostrum. From an animal perspective, 
calves fed colostrum treated with either ultraviolet light or heat had lower serum level 
of immunoglobulin isotype G when compared to calves fed raw colostrum. Animals 
receiving ultraviolet light and heat treated colostrum and non-saleable milk during the 
pre-weaning period presented similar growth, incidence of diseases, and mortality 
rates. Acknowledging that this study was conducted in a single and well-managed 
farm, we found significant results regarding calf performance that were not related to 
colostrum and milk treatments; dam’s parity, metritis of the dam, and calf birth weight 
were significantly associated with calf survivability. Parity, calf birth weight, and 
parturition assistance were significantly associated with the incidence of diarrhea. 
Metritis and retained placenta of the dam were significantly associated with calf 
pneumonia. Future studies should be conducted to evaluate the immunological status 
of the pregnant cow and the immunological status its offspring. Association between 
dam`s health events in the post-partum and its offspring survival were found and were 
independent from colostrum, since pooled colostrum was used.  
 In chapter two, understanding the immunological challenges on a neonatal 
animal can be largely influenced by nutrient availability; we proposed to evaluate the 
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effect of supplementation of trace minerals on the development and function of the 
immune system. We hypothesized that supplementation of injectable trace mineral 
(containing 60 mg of zinc, 10 mg of manganese, 5 mg of selenium, and 15 mg of 
copper) would lead to an improvement in pre-weaning dairy heifers’ immunological 
status, leading to decreased disease incidences and better growth performance during 
the pre-weaning period. For this study, we performed a randomized clinical trial using 
two commercial dairy farms and two different rearing systems (individual-housing fed 
restricted milk and group-housing fed unrestricted milk). Calves enrolled in this study 
were injected at three and thirty days of life. Immunological parameters, immune cell 
function, disease incidences, and body weight were measured at several points during 
the pre-weaning period. For both rearing systems, trace mineral supplementation was 
able to improve immune cell function (increasing leukocyte phagocytic ability), 
decrease incidence of diarrhea, and decrease incidence of combined respiratory 
disease and otitis. However, we could not observe a difference in calf body weight 
gain and mortality rates. More studies are needed to evaluate trace minerals levels in 
milk fed pre-weaned Holstein dairy calves to determine adequately when and which 
trace mineral should be supplemented.   
 In chapters three and four, we conducted two studies to test the efficacy of a 
natural product in reducing the dehydration caused by neonatal secretory diarrhea. 
This natural product, namely Crofelemer, has antisecretory properties that involve the 
inhibition of two distinct chloride channels on the luminal membrane of the intestine. 
In chapter three, we conducted a study to test if this natural product would aid calves 
under a single agent challenge. The microorganism of choice was enterotoxigenic 
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Escherichia coli known to mediate pathophysiological mechanisms of secretory 
diarrhea. During this study, fecal samples were collected to precisely quantify water 
content in feces. Data regarding fluid therapy intervention and body weight were also 
recorded. After challenged with enterotoxigenic E.coli, neonatal calves were treated 
twice daily consecutively for three days with a bolus of enteric-coated Crofelemer 
extract, or a non-enteric-coated bolus, or a placebo bolus. Calves suffering from 
secretory diarrhea in this study had significantly less water content in fecal samples 
during treatment days when receiving twice daily treatment of enteric-coated bolus 
containing Crofelemer. After this first design, we decided to test how this natural 
compound would perform under natural calf rearing conditions. The study presented 
in chapter four was designed to test if this compound would reduce water secretion 
and aid milk fed calves suffering from diarrhea under natural conditions. For this 
study, calves were enrolled to receive a constant dose of an extract (mixed with milk 
at feeding times) containing Crofelemer during the first two weeks of life. The data 
collected in this trial was similar to the previous study; fecal dry matter, body weight, 
and fluid therapy administration. Calves under crofelemer administration presented 
lower water content in fecal samples, fewer incidence of diarrhea, and had fewer fluid 
therapy interventions during the first 25 days of life. The ability of this molecule to 
regulate water secretion during events of secretory diarrhea is highly dependent of its 
ability to bind to chloride channels. Future studies should be conducted to investigate 
the prevalence of those chloride channels in cattle, equine, and swine. 
 In chapter five, we developed a study to address an important aspect of the 
modern replacement dairy heifer facility; the group-housing of newborn calves during 
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the pre-weaning period and its higher risk of calfhood disease. For this study we 
selected a long acting antimicrobial to test two metaphylactic approaches; one 
administration (at 10 days of life) and two administrations (at 10 and 35 days of life). 
A randomized clinical trial was conducted on a commercial dairy farm where newborn 
heifers were group-housed (25 calves per group) and fed unrestricted amounts of 
acidified milk. Diseases incidences and body weight data were collected. In this set-up 
we observed that both metaphylaxis treatments significantly reduced respiratory 
disease and otitis disease incidence. However, we could not observe an effect of 
metaphylaxis on calf weight gain and mortality rate. Carefully and strategically, long-
acting antibiotic metaphylaxis could be used to decrease the incidence of these 
diseases in high-risk group-housed replacement heifers during the pre-weaning period. 
 In chapter six, our objective was to determine if there was an association 
between lung lesions detected by ultrasonography at weaning and later performance in 
replacement dairy heifers. This study was conducted on a commercial dairy farm 
where calves were classified as not having lung consolidation or with lung 
consolidation at 60 days of life. Productivity and reproductive performance data were 
retrieved from farm data records. Here, we observed a higher hazard of being removed 
from the herd, a lower pregnancy to first service, and a lower hazard of pregnancy for 
nulliparous animals with lung consolidation detected at weaning when compared to 
heifers without lung consolidation. However, we could not observe a difference in 
milk production. We proposed that thoracic ultrasonography performed once at 
weaning could be used as a calf-side tool to improve heifers’ management.   
  
